<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Drug addiction,Articles with unsourced statements since December 2008,Articles needing additional references from September 2007,Fact,18-methoxycoronaridine,AMPA,AMPAR,Acamprosate,Acupressure,Acupuncture,Addiction" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Drug_addiction&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Drug_addiction&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Drug addiction - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Drug_addiction";
		var wgTitle = "Drug addiction";
		var wgAction = "view";
		var wgArticleId = "102961";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 280769419;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Drug_addiction skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Drug addiction</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table style="margin: 0 0 1em 1em; border: 1px solid #AAA; float: right;" cellpadding="0" cellspacing="0">
<tr>
<th style="padding: 0 5px; background: #CCF; text-align: center;"><a href="/wiki/Drug_abuse" title="Drug abuse">Drug abuse</a></th>
</tr>
<tr>
<td style="font-size: 90%; padding: 0 5px;"><strong class="selflink">Drug addiction</strong></td>
</tr>
<tr>
<td style="font-size: 90%; padding: 0 5px;"><a href="/wiki/Substance_abuse" title="Substance abuse">Substance abuse</a></td>
</tr>
</table>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Rational_scale_to_assess_the_harm_of_drugs_(mean_physical_harm_and_mean_dependence).svg" class="image" title="Comparison of the perceived harm for various psychoactive drugs from a poll among medical psychiatrists specialized in addiction treatment[1]"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/9/9c/Rational_scale_to_assess_the_harm_of_drugs_%28mean_physical_harm_and_mean_dependence%29.svg/180px-Rational_scale_to_assess_the_harm_of_drugs_%28mean_physical_harm_and_mean_dependence%29.svg.png" width="180" height="180" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Rational_scale_to_assess_the_harm_of_drugs_(mean_physical_harm_and_mean_dependence).svg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Comparison of the perceived harm for various psychoactive drugs from a poll among medical psychiatrists specialized in addiction treatment<sup id="cite_ref-Nutt_0-0" class="reference"><a href="#cite_note-Nutt-0" title=""><span>[</span>1<span>]</span></a></sup></div>
</div>
</div>
<div class="rellink boilerplate seealso">See also: <a href="/wiki/Addiction" title="Addiction">addiction</a></div>
<p><b><a href="/wiki/Drug" title="Drug">Drug</a> <a href="/wiki/Addiction" title="Addiction">addiction</a></b> is a <a href="/wiki/Pathology" title="Pathology">pathological condition</a>. The disorder of <a href="/wiki/Addiction" title="Addiction">addiction</a> involves the progression of acute <a href="/wiki/Drug_use" title="Drug use">drug use</a> to the development of drug-seeking behavior, the vulnerability to relapse, and the decreased, slowed ability to respond to naturally rewarding stimuli. The <a href="/wiki/DSM-IV" title="DSM-IV" class="mw-redirect">Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition</a> (DSM-IV) has categorized three stages of addiction: preoccupation/anticipation, binge/intoxication, and withdrawal/negative affect. These stages are characterized, respectively, everywhere by constant cravings and preoccupation with obtaining the substance; using more of the substance than necessary to experience the intoxicating effects; and experiencing tolerance, withdrawal symptoms, and decreased motivation for normal life activities.<sup id="cite_ref-Koob_and_Kreek_1-0" class="reference"><a href="#cite_note-Koob_and_Kreek-1" title=""><span>[</span>2<span>]</span></a></sup> By the American Society of Addiction Medicine definition, drug addiction differs from <a href="/wiki/Drug_dependence" title="Drug dependence" class="mw-redirect">drug dependence</a> and <a href="/wiki/Drug_tolerance" title="Drug tolerance">drug tolerance</a>.<sup id="cite_ref-painmed_2-0" class="reference"><a href="#cite_note-painmed-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p>It is, both among scientists and other writers, quite usual to allow the concept of drug addiction to include persons who are not drug abusers according to the definition of the American Society of Addiction Medicine. The term drug addiction is then used as a category which may include the same persons who under the <a href="/wiki/DSM-IV" title="DSM-IV" class="mw-redirect">DSM-IV</a> can be given the diagnosis of <a href="/wiki/Substance_dependence" title="Substance dependence">substance dependence</a> or <a href="/wiki/Substance_abuse" title="Substance abuse">substance abuse</a>. (See also <a href="/wiki/DSM-IV_Codes" title="DSM-IV Codes">DSM-IV Codes</a>)</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Drugs_causing_addiction"><span class="tocnumber">1</span> <span class="toctext">Drugs causing addiction</span></a>
<ul>
<li class="toclevel-2"><a href="#Addictive_potency"><span class="tocnumber">1.1</span> <span class="toctext">Addictive potency</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Prevalence"><span class="tocnumber">2</span> <span class="toctext">Prevalence</span></a></li>
<li class="toclevel-1"><a href="#The_physiological_basis_of_drug_addiction"><span class="tocnumber">3</span> <span class="toctext">The physiological basis of drug addiction</span></a>
<ul>
<li class="toclevel-2"><a href="#Acute_effects"><span class="tocnumber">3.1</span> <span class="toctext">Acute effects</span></a></li>
<li class="toclevel-2"><a href="#Reward_circuit"><span class="tocnumber">3.2</span> <span class="toctext">Reward circuit</span></a></li>
<li class="toclevel-2"><a href="#Stress_response"><span class="tocnumber">3.3</span> <span class="toctext">Stress response</span></a></li>
<li class="toclevel-2"><a href="#Behavior"><span class="tocnumber">3.4</span> <span class="toctext">Behavior</span></a></li>
<li class="toclevel-2"><a href="#Allostasis"><span class="tocnumber">3.5</span> <span class="toctext">Allostasis</span></a></li>
<li class="toclevel-2"><a href="#Neuroplasticity"><span class="tocnumber">3.6</span> <span class="toctext">Neuroplasticity</span></a></li>
<li class="toclevel-2"><a href="#Neurogenesis"><span class="tocnumber">3.7</span> <span class="toctext">Neurogenesis</span></a></li>
<li class="toclevel-2"><a href="#Psychological_drug_tolerance"><span class="tocnumber">3.8</span> <span class="toctext">Psychological drug tolerance</span></a></li>
<li class="toclevel-2"><a href="#Sensitization"><span class="tocnumber">3.9</span> <span class="toctext">Sensitization</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Individual_mechanisms_of_effect"><span class="tocnumber">4</span> <span class="toctext">Individual mechanisms of effect</span></a>
<ul>
<li class="toclevel-2"><a href="#Depressants"><span class="tocnumber">4.1</span> <span class="toctext">Depressants</span></a></li>
<li class="toclevel-2"><a href="#Stimulants"><span class="tocnumber">4.2</span> <span class="toctext">Stimulants</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Theories_about_causes_for_epidemic_outbreak_of_addiction"><span class="tocnumber">5</span> <span class="toctext">Theories about causes for epidemic outbreak of addiction</span></a>
<ul>
<li class="toclevel-2"><a href="#Nils_Bejerot"><span class="tocnumber">5.1</span> <span class="toctext">Nils Bejerot</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Treatment"><span class="tocnumber">6</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2"><a href="#Residential"><span class="tocnumber">6.1</span> <span class="toctext">Residential</span></a>
<ul>
<li class="toclevel-3"><a href="#12_step_program"><span class="tocnumber">6.1.1</span> <span class="toctext">12 step program</span></a></li>
</ul>
</li>
<li class="toclevel-2"><a href="#Anti-addictive_drugs"><span class="tocnumber">6.2</span> <span class="toctext">Anti-addictive drugs</span></a></li>
<li class="toclevel-2"><a href="#Alternative_therapies"><span class="tocnumber">6.3</span> <span class="toctext">Alternative therapies</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Medical_definitions"><span class="tocnumber">7</span> <span class="toctext">Medical definitions</span></a></li>
<li class="toclevel-1"><a href="#Addiction_and_drug_control_legislation"><span class="tocnumber">8</span> <span class="toctext">Addiction and drug control legislation</span></a></li>
<li class="toclevel-1"><a href="#History_of_addiction"><span class="tocnumber">9</span> <span class="toctext">History of addiction</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">10</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#Literature"><span class="tocnumber">11</span> <span class="toctext">Literature</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">12</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#Sources"><span class="tocnumber">13</span> <span class="toctext">Sources</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">14</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Drugs_causing_addiction" id="Drugs_causing_addiction"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=1" title="Edit section: Drugs causing addiction">edit</a>]</span> <span class="mw-headline">Drugs causing addiction</span></h2>
<p>Drugs known to cause addiction include illegal drugs as well as <a href="/wiki/Prescription_drug" title="Prescription drug">prescription</a> or <a href="/wiki/Over-the-counter_drug" title="Over-the-counter drug">over-the-counter drugs</a>, according to the definition of the American Society of Addiction Medicine.</p>
<ul>
<li><a href="/wiki/Stimulant" title="Stimulant">Stimulants</a>:
<ul>
<li><a href="/wiki/Amphetamine" title="Amphetamine">Amphetamine</a> and <a href="/wiki/Methamphetamine" title="Methamphetamine">Methamphetamine</a></li>
<li><a href="/wiki/Caffeine" title="Caffeine">Caffeine</a></li>
<li><a href="/wiki/Cocaine" title="Cocaine">Cocaine</a></li>
<li><a href="/wiki/Nicotine" title="Nicotine">Nicotine</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Sedative" title="Sedative">Sedatives</a> and <a href="/wiki/Hypnotic" title="Hypnotic">Hypnotics</a>:
<ul>
<li><a href="/wiki/Alcohol" title="Alcohol">Alcohol</a></li>
<li><a href="/wiki/Barbiturate" title="Barbiturate">Barbiturates</a></li>
<li><a href="/wiki/Benzodiazepines" title="Benzodiazepines" class="mw-redirect">Benzodiazepines</a>, particularly <a href="/wiki/Flunitrazepam" title="Flunitrazepam">flunitrazepam</a>, <a href="/wiki/Triazolam" title="Triazolam">triazolam</a>, <a href="/wiki/Temazepam" title="Temazepam">temazepam</a>, and <a href="/wiki/Nimetazepam" title="Nimetazepam">nimetazepam</a></li>
<li><a href="/wiki/Methaqualone" title="Methaqualone">Methaqualone</a> and the related <a href="/wiki/Quinazolinone" title="Quinazolinone">quinazolinone</a> sedative-hypnotics</li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Opiate" title="Opiate">Opiate</a> and <a href="/wiki/Opioid" title="Opioid">Opioid</a> <a href="/wiki/Analgesics" title="Analgesics" class="mw-redirect">analgesics</a>
<ul>
<li><a href="/wiki/Morphine" title="Morphine">Morphine</a> and <a href="/wiki/Codeine" title="Codeine">Codeine</a>, the two naturally-occurring opiate analgesics</li>
<li>Semi-synthetic opiates, such as <a href="/wiki/Heroin" title="Heroin">Heroin</a> (Diacetylmorphine), <a href="/wiki/Oxycodone" title="Oxycodone">Oxycodone</a>, <a href="/wiki/Hydrocodone" title="Hydrocodone">Hydrocodone</a>, and <a href="/wiki/Hydromorphone" title="Hydromorphone">Hydromorphone</a></li>
<li>Fully synthetic opioids, such as <a href="/wiki/Fentanyl" title="Fentanyl">Fentanyl</a> and its analogs, <a href="/wiki/Meperidine" title="Meperidine" class="mw-redirect">Meperidine</a>/Pethidine, and <a href="/wiki/Methadone" title="Methadone">Methadone</a></li>
</ul>
</li>
</ul>
<p>Addictive drugs also include a large number of substrates that are currently considered to have no medical value and are not available over the counter or by prescription.</p>
<p>An article in <a href="/wiki/The_Lancet" title="The Lancet"><i>The Lancet</i></a> compared the harm and addiction of 20 drugs, using a scale from 0 to 3 for physical addiction, psychological addiction, and pleasure to create a mean score for addiction. Caffeine was not included in the study. The results can be seen in the chart above.</p>
<p><a name="Addictive_potency" id="Addictive_potency"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=2" title="Edit section: Addictive potency">edit</a>]</span> <span class="mw-headline">Addictive potency</span></h3>
<p>The addictive potency of drugs varies from substance to substance, and from individual to individual</p>
<p>Drugs such as <a href="/wiki/Codeine" title="Codeine">codeine</a> or <a href="/wiki/Alcohol" title="Alcohol">alcohol</a>, for instance, typically require many more exposures to addict their users than drugs such as <a href="/wiki/Heroin" title="Heroin">heroin</a> or <a href="/wiki/Cocaine" title="Cocaine">cocaine</a>. Likewise, a person who is psychologically or <a href="/wiki/Genetics" title="Genetics">genetically</a> predisposed to addiction is much more likely to suffer from it.</p>
<p>Although dependency on hallucinogens like <a href="/wiki/LSD" title="LSD" class="mw-redirect">LSD</a> ("acid") and <a href="/wiki/Psilocybin" title="Psilocybin">psilocybin</a> (key hallucinogen in "<a href="/wiki/Magic_mushroom" title="Magic mushroom" class="mw-redirect">magic mushrooms</a>") is listed as Substance-Related Disorder in the <a href="/wiki/DSM-IV_Codes#Hallucinogen-Related_Disorders" title="DSM-IV Codes">DSM-IV</a>, most psychologists do not classify them as addictive drugs.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since December 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p><a name="Prevalence" id="Prevalence"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=3" title="Edit section: Prevalence">edit</a>]</span> <span class="mw-headline">Prevalence</span></h2>
<p>The most common drug addictions are to legal substances such as:</p>
<ul>
<li><a href="/wiki/Caffeine" title="Caffeine">Caffeine</a></li>
<li><a href="/wiki/Nicotine" title="Nicotine">Nicotine</a> in the form of <a href="/wiki/Tobacco" title="Tobacco">tobacco</a>, particularly <a href="/wiki/Cigarette" title="Cigarette">cigarettes</a></li>
<li><a href="/wiki/Alcohol" title="Alcohol">Alcohol</a></li>
</ul>
<p><a name="The_physiological_basis_of_drug_addiction" id="The_physiological_basis_of_drug_addiction"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=4" title="Edit section: The physiological basis of drug addiction">edit</a>]</span> <span class="mw-headline">The physiological basis of drug addiction</span></h2>
<p>Researchers have conducted numerous investigations using animal models and functional brain imaging on humans in order to define the mechanisms underlying drug addiction in the brain. This intriguing topic incorporates several areas of the brain and synaptic changes, or <a href="/wiki/Neuroplasticity" title="Neuroplasticity">neuroplasticity</a>, which occurs in these areas.</p>
<p><a name="Acute_effects" id="Acute_effects"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=5" title="Edit section: Acute effects">edit</a>]</span> <span class="mw-headline">Acute effects</span></h3>
<p>Acute (or recreational) <a href="/wiki/Recreational_drug_use" title="Recreational drug use">drug use</a> causes the release and prolonged action of <a href="/wiki/Dopamine" title="Dopamine">dopamine</a> and <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> within the reward circuit. Different types of drugs produce these effects by different methods. <a href="/wiki/Dopamine" title="Dopamine">Dopamine</a> (DA) appears to harbor the largest effect and its action is characterized. DA binds to the <a href="/wiki/D1_receptor" title="D1 receptor" class="mw-redirect">D1 receptor</a>, triggering a signaling cascade within the cell. <a href="/wiki/CAMP-dependent_protein_kinase" title="CAMP-dependent protein kinase" class="mw-redirect">cAMP-dependent protein kinase</a> (PKA) phosphorylates <a href="/wiki/CAMP_response_element_binding_protein" title="CAMP response element binding protein" class="mw-redirect">cAMP response element binding protein</a> (CREB), a transcription factor, which induces the synthesis of certain genes including <a href="/wiki/C-Fos" title="C-Fos">C-Fos</a>.<sup id="cite_ref-Kalivas_and_Volkow_3-0" class="reference"><a href="#cite_note-Kalivas_and_Volkow-3" title=""><span>[</span>4<span>]</span></a></sup></p>
<p><a name="Reward_circuit" id="Reward_circuit"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=6" title="Edit section: Reward circuit">edit</a>]</span> <span class="mw-headline">Reward circuit</span></h3>
<p>When examining the biological basis of drug addiction, one must first understand the pathways in which drugs act and how drugs can alter those pathways. The <a href="/wiki/Reward_system" title="Reward system">reward circuit</a>, also referred to as the <a href="/wiki/Mesolimbic_system" title="Mesolimbic system" class="mw-redirect">mesolimbic system</a>, is characterized by the interaction of several areas of the brain.</p>
<ul>
<li>The <a href="/wiki/Ventral_tegmentum" title="Ventral tegmentum">ventral tegmental area</a> (VTA) consists of <a href="/wiki/Dopaminergic" title="Dopaminergic">dopaminergic</a> <a href="/wiki/Neurons" title="Neurons" class="mw-redirect">neurons</a> which respond to <a href="/wiki/Glutamate" title="Glutamate" class="mw-redirect">glutamate</a>. These cells respond when stimuli indicative of a reward are present. The VTA supports learning and sensitization development and releases <a href="/wiki/Dopamine" title="Dopamine">dopamine</a> (DA) into the <a href="/wiki/Forebrain" title="Forebrain" class="mw-redirect">forebrain</a>.<sup id="cite_ref-Jones_and_Bonci_4-0" class="reference"><a href="#cite_note-Jones_and_Bonci-4" title=""><span>[</span>5<span>]</span></a></sup> These neurons also project and release DA into the nucleus accubems<sup id="cite_ref-Eisch_and_Harburg_5-0" class="reference"><a href="#cite_note-Eisch_and_Harburg-5" title=""><span>[</span>6<span>]</span></a></sup>, through the <a href="/wiki/Mesolimbic_pathway" title="Mesolimbic pathway">mesolimbic pathway</a>. Virtually all drugs causing drug addiction increase the dopamine release in the mesolimbic pathway,<sup id="cite_ref-Rang_6-0" class="reference"><a href="#cite_note-Rang-6" title=""><span>[</span>7<span>]</span></a></sup> in addition to their specific effects.</li>
<li>The <a href="/wiki/Nucleus_accumbens" title="Nucleus accumbens">nucleus accumbens</a> (NAcc) consists mainly of medium-spiny projection neurons (MSNs), which are <a href="/wiki/GABA" title="GABA" class="mw-redirect">GABA</a> neurons.<sup id="cite_ref-Kourrich_7-0" class="reference"><a href="#cite_note-Kourrich-7" title=""><span>[</span>8<span>]</span></a></sup> The NAcc is associated with acquiring and eliciting conditioned behaviors and involved in the increased sensitivity to drugs as addiction progresses.<sup id="cite_ref-Jones_and_Bonci_4-1" class="reference"><a href="#cite_note-Jones_and_Bonci-4" title=""><span>[</span>5<span>]</span></a></sup></li>
<li>The <a href="/wiki/Prefrontal_cortex" title="Prefrontal cortex">prefrontal cortex</a>, more specifically the <a href="/wiki/Anterior_cingulate" title="Anterior cingulate" class="mw-redirect">anterior cingulate</a> and <a href="/wiki/Orbitofrontal_cortex" title="Orbitofrontal cortex">orbitofrontal</a> cortices,<sup id="cite_ref-Kalivas_and_Volkow_3-1" class="reference"><a href="#cite_note-Kalivas_and_Volkow-3" title=""><span>[</span>4<span>]</span></a></sup> is important for the integration of information which contributes to whether a behavior will be elicited. It appears to be the area in which motivation originates and the salience of stimuli are determined.<sup id="cite_ref-Floresco_8-0" class="reference"><a href="#cite_note-Floresco-8" title=""><span>[</span>9<span>]</span></a></sup></li>
<li>The <a href="/wiki/Basolateral_amygdala" title="Basolateral amygdala" class="mw-redirect">basolateral amygdala</a> projects into the NAcc and is thought to be important for motivation as well.<sup id="cite_ref-Floresco_8-1" class="reference"><a href="#cite_note-Floresco-8" title=""><span>[</span>9<span>]</span></a></sup></li>
<li>More evidence is pointing towards the role of the <a href="/wiki/Hippocampus" title="Hippocampus">hippocampus</a> in drug addiction because of its importance in learning and memory. Much of this evidence stems from investigations manipulating cells in the hippocampus alters dopamine levels in NAcc and firing rates of VTA dopaminergic cells.<sup id="cite_ref-Eisch_and_Harburg_5-1" class="reference"><a href="#cite_note-Eisch_and_Harburg-5" title=""><span>[</span>6<span>]</span></a></sup></li>
</ul>
<p><a name="Stress_response" id="Stress_response"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=7" title="Edit section: Stress response">edit</a>]</span> <span class="mw-headline">Stress response</span></h3>
<dl>
<dd>see also <a href="/wiki/Stress_response" title="Stress response" class="mw-redirect">Stress response</a></dd>
</dl>
<p>In addition to the reward circuit, it is hypothesized that stress mechanisms also play a role in addiction. Koob and Kreek have hypothesized that during drug use <a href="/wiki/Corticotropin-releasing_hormone" title="Corticotropin-releasing hormone">corticotropin-releasing factor</a> (CRF) activates the <a href="/wiki/Hypothalamic-pituitary-adrenal_axis" title="Hypothalamic-pituitary-adrenal axis">hypothalamic-pituitary-adrenal axis</a> (HPA) and other stress systems in the extended <a href="/wiki/Amygdala" title="Amygdala">amygdala</a>. This activation influences the dysregulated emotional state associated with drug addiction. They have found that as drug use escalates, so does the presence of CRF in human <a href="/wiki/Cerebrospinal_fluid" title="Cerebrospinal fluid">cerebrospinal fluid</a> (CSF). In rat models, the separate use of CRF antagonists and CRF receptor antagonists both decreased self-administration of the drug of study. Other studies in this review showed a dysregulation in other hormones associated with the HPA axis, including <a href="/wiki/Enkephalin" title="Enkephalin">enkephalin</a> which is an endogenous <a href="/wiki/Opioid_peptides" title="Opioid peptides" class="mw-redirect">opioid peptides</a> that regulates pain. It also appears that the <a href="/wiki/Mu_Opioid_receptor" title="Mu Opioid receptor">µ-opioid receptor</a> system, which enkephalin acts on, is influential in the reward system and can regulate the expression of <a href="/wiki/Stress_hormones" title="Stress hormones" class="mw-redirect">stress hormones</a>.<sup id="cite_ref-Koob_and_Kreek_1-1" class="reference"><a href="#cite_note-Koob_and_Kreek-1" title=""><span>[</span>2<span>]</span></a></sup></p>
<p><a name="Behavior" id="Behavior"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=8" title="Edit section: Behavior">edit</a>]</span> <span class="mw-headline">Behavior</span></h3>
<p>Understanding how <a href="/wiki/Learning" title="Learning">learning</a> and <a href="/wiki/Behavior" title="Behavior">behavior</a> work in the <a href="/wiki/Reward_circuit" title="Reward circuit" class="mw-redirect">reward circuit</a> can help understand the action of addictive drugs. Drug addiction is characterized by strong, drug seeking behaviors in which the addict persistently craves and seeks out drugs, despite the knowledge of harmful consequences.<sup id="cite_ref-Kalivas_and_Volkow_3-2" class="reference"><a href="#cite_note-Kalivas_and_Volkow-3" title=""><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Koob_and_Kreek_1-2" class="reference"><a href="#cite_note-Koob_and_Kreek-1" title=""><span>[</span>2<span>]</span></a></sup> Addictive drugs produce a reward, which is the euphoric feeling resulting from sustained DA concentrations in the synaptic cleft of neurons in the brain. <a href="/wiki/Operant_conditioning" title="Operant conditioning">Operant conditioning</a> is exhibited in drug addicts as well as laboratory mice, rats, and primates; they are able to associate an action or behavior, in this case seeking out the drug, with a reward, which is the effect of the drug.<sup id="cite_ref-Jones_and_Bonci_4-2" class="reference"><a href="#cite_note-Jones_and_Bonci-4" title=""><span>[</span>5<span>]</span></a></sup> Evidence shows that this behavior is most likely a result of the synaptic changes which have occurred due to repeated drug exposure.<sup id="cite_ref-Kalivas_and_Volkow_3-3" class="reference"><a href="#cite_note-Kalivas_and_Volkow-3" title=""><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Koob_and_Kreek_1-3" class="reference"><a href="#cite_note-Koob_and_Kreek-1" title=""><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Jones_and_Bonci_4-3" class="reference"><a href="#cite_note-Jones_and_Bonci-4" title=""><span>[</span>5<span>]</span></a></sup> The drug seeking behavior is induced by glutamatergic projections from the prefrontal cortex to the NAc. This idea is supported with data from experiments showing the drug seeking behavior can be prevented following the inhibition of <a href="/wiki/AMPA" title="AMPA">AMPA</a> glutamate receptors and glutamate release in the NAc.<sup id="cite_ref-Kalivas_and_Volkow_3-4" class="reference"><a href="#cite_note-Kalivas_and_Volkow-3" title=""><span>[</span>4<span>]</span></a></sup></p>
<p><a name="Allostasis" id="Allostasis"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=9" title="Edit section: Allostasis">edit</a>]</span> <span class="mw-headline">Allostasis</span></h3>
<p><a href="/wiki/Allostasis" title="Allostasis">Allostasis</a> is the process of achieving stability through changes in behavior as well as physiological features. As a person progresses into drug addiction, he or she appears to enter a new allostatic state, defined as divergence from normal levels of change which persist in a chronic state. Addiction to drugs can cause damage to your brain and body as you enter the pathological state; the cost stemming from damage is known as allostatic load. The dysregulation of allostasis gradually occurs as the reward from the drug decreases and the ability to overcome the depressed state following drug use begins to decrease as well. The resulting allostatic load creates a constant state of depression relative to normal allostatic changes. What pushes this decrease is the propensity of drug users to take the drug before the brain and body have returned to original allostatic levels, producing a constant state of stress. Therefore, the presence of environmental stressors may induce stronger drug seeking behaviors.<sup id="cite_ref-Koob_and_Kreek_1-4" class="reference"><a href="#cite_note-Koob_and_Kreek-1" title=""><span>[</span>2<span>]</span></a></sup></p>
<p><a name="Neuroplasticity" id="Neuroplasticity"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=10" title="Edit section: Neuroplasticity">edit</a>]</span> <span class="mw-headline">Neuroplasticity</span></h3>
<p><a href="/wiki/Neuroplasticity" title="Neuroplasticity">Neuroplasticity</a> is the putative mechanism behind learning and memory. It involves physical changes in the synapses between two communicating neurons, characterized by increased gene expression, altered cell signaling, and the formation of new synapses between the communicating neurons. When addictive drugs are present in the system, they appear to hijack this mechanism in the reward system so that motivation is geared towards procuring the drug rather than natural rewards.<sup id="cite_ref-Jones_and_Bonci_4-4" class="reference"><a href="#cite_note-Jones_and_Bonci-4" title=""><span>[</span>5<span>]</span></a></sup> Depending on the history of drug use, excitatory synapses in the <a href="/wiki/Nucleus_accumbens" title="Nucleus accumbens">nucleus accumbens</a>(NAc) experience two types of neuroplasticity: <a href="/wiki/Long-term_potentiation" title="Long-term potentiation">long-term potentiation</a> (LTP) and <a href="/wiki/Long-term_depression" title="Long-term depression">long-term depression</a> (LTD). Using mice as a model, Kourrich <i>et al.</i> showed that chronic exposure to cocaine increases the strength of synapses in NAc after a 10-14 day withdrawal period, while strengthened synapses did not appear within a 24 hour withdrawal period after repeated cocaine exposure. A single dose of cocaine did not elicit any attributes of a strengthened synapse. When drug-experienced mice were challenged with one dose of cocaine, synaptic depression occurred. Therefore, it seems the history of cocaine exposure along with withdrawal times affects the direction of glutamatergic plasticity in the NAc.<sup id="cite_ref-Kourrich_7-1" class="reference"><a href="#cite_note-Kourrich-7" title=""><span>[</span>8<span>]</span></a></sup></p>
<p>Once a person has transitioned from drug use to addiction, behavior becomes completely geared towards seeking the drug, even though addicts report the euphoria is not as intense as it once was. Despite the differing actions of drugs during acute use, the final pathway of addiction is the same. Another aspect of drug addiction is a decreased response to normal biological stimuli, such as food, sex, and social interaction. Through functional brain imaging of patients addicted to cocaine, scientists have been able to visualize increased metabolic activity in the <a href="/wiki/Anterior_cingulate" title="Anterior cingulate" class="mw-redirect">anterior cingulate</a> and <a href="/wiki/Orbitofrontal_cortex" title="Orbitofrontal cortex">orbitofrontal cortex</a> (areas of the prefrontal cortex) in the brain of these subjects. The hyperactivity of these areas of the brain in addicted subjects is involved in the more intense motivation to find the drug rather than seeking natural rewards, as well as an addict’s decreased ability to overcome this urge. Brain imaging has also shown cocaine-addicted subjects to have decreased activity, as compared to non-addicts, in their prefrontal cortex when presented with stimuli associated with natural rewards. The transition from recreational drug use to addiction occurs in gradual stages and is produced by the effect of the drug of choice on the neuroplasticity of the neurons found in the reward circuit. During events preceding addiction, cravings are produced by the release of DA in the prefrontal cortex. As a person transitions from drug use to addiction, the release of dopamine (DA) in the NAc becomes unnecessary to produce cravings; rather, DA transmission decreases while increased metabolic activity in the orbitofrontal cortex contributes to cravings. At this time a person may experience the signs of depression if cocaine is not used. <sup id="cite_ref-9" class="reference"><a href="#cite_note-9" title=""><span>[</span>10<span>]</span></a></sup> Before a person becomes addicted and exhibits drug-seeking behavior, there is a time period in which the neuroplasticity is reversible. Addiction occurs when drug-seeking behavior is exhibited and the vulnerability to relapse persists, despite prolonged withdrawal; these behavioral attributes are the result of neuroplastic changes which are brought about by repeated exposure to drugs and are relatively permanent.<sup id="cite_ref-Kalivas_and_Volkow_3-5" class="reference"><a href="#cite_note-Kalivas_and_Volkow-3" title=""><span>[</span>4<span>]</span></a></sup></p>
<p>The exact mechanism behind a drug molecule’s effect on synaptic plasticity is still unclear. However, neuroplasticity in glutamatergic projections seems to be a major result of repeated drug exposure. There are several ways in which glutamate transmission is altered. One way is by increasing presynaptic release of glutamate and the other is increased response to glutamate.<sup id="cite_ref-Kalivas_and_Volkow_3-6" class="reference"><a href="#cite_note-Kalivas_and_Volkow-3" title=""><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Jones_and_Bonci_4-5" class="reference"><a href="#cite_note-Jones_and_Bonci-4" title=""><span>[</span>5<span>]</span></a></sup> The two main glutamate receptors involved are <a href="/wiki/NMDAR" title="NMDAR" class="mw-redirect">NMDAR</a> and <a href="/wiki/AMPAR" title="AMPAR" class="mw-redirect">AMPAR</a>. The expression of these receptors on the cell surface increases with repeated drug use. This type of synaptic plasticity results in LTP, which strengthens connections between two neurons; onset of this occurs quickly and the result is constant. In addition to glutamatergic neurons, dopaminergic neurons present in the VTA respond to glutamate and may be recruited earliest during neural adaptations caused by repeated drug exposure. As shown by Kourrich, et al, history of drug exposure and the time of withdrawal from last exposure appear to play an important role in the direction of plasticity in the neurons of the reward system.<sup id="cite_ref-Jones_and_Bonci_4-6" class="reference"><a href="#cite_note-Jones_and_Bonci-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p>An aspect of neuron development that may also play a part in drug-induced neuroplasticity is the presence of axon guidance molecules such as semaphorins and ephrins. After repeated cocaine treatment, altered expression (increase or decrease dependent on the type of molecule) of mRNA coding for axon guidance molecules occurred in rats. This may contribute to the alterations in the reward circuit characteristic of drug addiction.<sup id="cite_ref-Bahi_and_Dreyer_10-0" class="reference"><a href="#cite_note-Bahi_and_Dreyer-10" title=""><span>[</span>11<span>]</span></a></sup></p>
<p><a name="Neurogenesis" id="Neurogenesis"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=11" title="Edit section: Neurogenesis">edit</a>]</span> <span class="mw-headline">Neurogenesis</span></h3>
<p>Drug addiction also raises the issue of potential harmful effects on the development of new neurons in adults. Eisch and Harburg raise three new concepts they have extrapolated from the numerous recent studies on drug addiction. First, <a href="/wiki/Neurogenesis" title="Neurogenesis">neurogenesis</a> decreases as a result of repeated exposure to addictive drugs. A list of studies show that chronic use of opiates, psychostimulants, nicotine, and alcohol decrease neurogenesis in mice and rats. Second, this apparent decrease in neurogenesis seems to be independent of HPA axis activation. Other environmental factors other than drug exposure such as age, stress and exercise, can also have an effect of neurogenesis by regulating the hypothalamic-pituitary-adrenal (HPA) axis. Mounting evidence suggests this for 3 reasons: small doses of opiates and psychostimulants increase coricosterone concentration in serum but with no effect of neurogenesis; although decreased neurogenesis is similar between self-administered and forced drug intake, activation of HPA axis is greater in self-administration subjects; and even after the inhibition of opiate induced increase of corticosterone, a decrease in neurogenesis occurred. These, of course, need to be investigated further. Last, addictive drugs appear to only affect proliferation in the <a href="/wiki/Neurogenesis" title="Neurogenesis">subgranular zone</a> (SGZ), rather than other areas associated with neurogenesis. The studies of drug use and neurogenesis may have implications on stem cell biology.<sup id="cite_ref-Eisch_and_Harburg_5-2" class="reference"><a href="#cite_note-Eisch_and_Harburg-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p><a name="Psychological_drug_tolerance" id="Psychological_drug_tolerance"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=12" title="Edit section: Psychological drug tolerance">edit</a>]</span> <span class="mw-headline">Psychological drug tolerance</span></h3>
<p>The reward system is partly responsible for the <a href="/wiki/Psychological" title="Psychological" class="mw-redirect">psychological</a> part of <a href="/wiki/Drug_tolerance" title="Drug tolerance">drug tolerance</a>;</p>
<p>The <a href="/wiki/CREB" title="CREB">CREB</a> protein, a <a href="/wiki/Transcription_factor" title="Transcription factor">transcription factor</a> activated by <a href="/wiki/Cyclic_adenosine_monophosphate" title="Cyclic adenosine monophosphate">cyclic adenosine monophosphate</a> (cAMP) immediately after a high, triggers <a href="/wiki/Gene" title="Gene">genes</a> that produce proteins such as <a href="/wiki/Dynorphin" title="Dynorphin">dynorphin</a>, which cuts off dopamine release and temporarily inhibits the reward circuit. In chronic drug users, a sustained activation of CREB thus forces a larger dose to be taken to reach the same effect. In addition it leaves the user feeling generally depressed and dissatisfied, and unable to find pleasure in previously enjoyable activities, often leading to a return to the drug for an additional "fix".<sup id="cite_ref-11" class="reference"><a href="#cite_note-11" title=""><span>[</span>12<span>]</span></a></sup>.</p>
<p><a name="Sensitization" id="Sensitization"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=13" title="Edit section: Sensitization">edit</a>]</span> <span class="mw-headline">Sensitization</span></h3>
<p>Sensitization is the increase in sensitivity to a drug after prolonged use. The proteins <a href="/wiki/Delta_FosB" title="Delta FosB" class="mw-redirect">delta FosB</a> and regulator of G-protein Signaling 9-2 (RGS 9-2) are thought to be involved:</p>
<p>A transcription factor, known as delta FosB, is thought to activate genes that, counter to the effects of CREB, actually increase the user's sensitivity to the effects of the substance. Delta FosB slowly builds up with each exposure to the drug and remains activated for weeks after the last exposure—long after the effects of CREB have faded. The hypersensitivity that it causes is thought to be responsible for the intense cravings associated with drug addiction, and is often extended to even the peripheral cues of drug use, such as related behaviors or the sight of drug paraphernalia. There is some evidence that delta FosB even causes structural changes within the <a href="/wiki/Nucleus_accumbens" title="Nucleus accumbens">nucleus accumbens</a>, which presumably helps to perpetuate the cravings, and may be responsible for the high incidence of relapse that occur in treated drug addicts.</p>
<p>Regulator of G-protein Signaling 9-2 (RGS 9-2) has recently been the subject of several animal knockout studies. Animals lacking RGS 9-2 appear to have increased sensitivity to dopamine receptor agonists such as cocaine and amphetamines; over-expression of RGS 9-2 causes a lack of responsiveness to these same agonists. RGS 9-2 is believed to catalyze inactivation of the G-protein coupled D2 receptor by enhancing the rate of GTP hydrolysis of the G alpha subunit which transmits signals into the interior of the cell.</p>
<p><a name="Individual_mechanisms_of_effect" id="Individual_mechanisms_of_effect"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=14" title="Edit section: Individual mechanisms of effect">edit</a>]</span> <span class="mw-headline">Individual mechanisms of effect</span></h2>
<p>The basic mechanisms by which different substances activate the <a href="/wiki/Reward_system" title="Reward system">reward system</a> are as described above, but vary slightly among drug classes.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12" title=""><span>[</span>13<span>]</span></a></sup>.</p>
<p><a name="Depressants" id="Depressants"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=15" title="Edit section: Depressants">edit</a>]</span> <span class="mw-headline">Depressants</span></h3>
<p><a href="/wiki/Depressant" title="Depressant">Depressants</a> such as <a href="/wiki/Alcohol" title="Alcohol">alcohol</a>, <a href="/wiki/Barbiturate" title="Barbiturate">barbiturates</a>, and <a href="/wiki/Benzodiazepine" title="Benzodiazepine">benzodiazepines</a> work by increasing the affinity of the GABA receptor for its ligand; GABA. <a href="/wiki/Narcotic" title="Narcotic">Narcotics</a> such as <a href="/wiki/Morphine" title="Morphine">morphine</a> and <a href="/wiki/Methadone" title="Methadone">methadone</a>, work by mimicking <a href="/wiki/Endorphin" title="Endorphin">endorphins</a>—chemicals produced naturally by the body which have effects similar to dopamine—or by disabling the <a href="/wiki/Neuron" title="Neuron">neurons</a> that normally inhibit the release of dopamine in the reward system. These substances (sometimes called "downers") typically facilitate relaxation and pain-relief.</p>
<p><a name="Stimulants" id="Stimulants"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=16" title="Edit section: Stimulants">edit</a>]</span> <span class="mw-headline">Stimulants</span></h3>
<p><a href="/wiki/Stimulant" title="Stimulant">Stimulants</a> such as <a href="/wiki/Amphetamine" title="Amphetamine">amphetamines</a>, <a href="/wiki/Nicotine" title="Nicotine">nicotine</a>, and <a href="/wiki/Cocaine" title="Cocaine">cocaine</a>, increase dopamine signaling in the reward system either by directly stimulating its release, or by blocking its absorption (see "<a href="/wiki/Reuptake" title="Reuptake">reuptake</a>"). These substances (sometimes called "uppers") typically cause heightened alertness and energy. They cause a pleasant feeling in the body, and euphoria, known as a high. This high wears off leaving the user feeling depressed. This sometimes makes them want more of the drug, and can worsen the addiction.</p>
<p><a name="Theories_about_causes_for_epidemic_outbreak_of_addiction" id="Theories_about_causes_for_epidemic_outbreak_of_addiction"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=17" title="Edit section: Theories about causes for epidemic outbreak of addiction">edit</a>]</span> <span class="mw-headline">Theories about causes for epidemic outbreak of addiction</span></h2>
<p><a name="Nils_Bejerot" id="Nils_Bejerot"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=18" title="Edit section: Nils Bejerot">edit</a>]</span> <span class="mw-headline">Nils Bejerot</span></h4>
<p><a href="/wiki/Nils_Bejerot" title="Nils Bejerot">Nils Bejerot</a> (1921 –1988) was a Swedish <a href="/wiki/Psychiatrist" title="Psychiatrist">psychiatrist</a> and <a href="/wiki/Criminologist" title="Criminologist">criminologist</a>. He attacked the symptom theory of addiction - that addictions are a symptom of other more fundamental personal or socioeconomic problems - and separated five essential factors from all of the other factors that are involved in addiction. Bejerot's point was that all of these other factors should be understood as susceptibility or risk factors. Therefore mental illness may make someone susceptible to drug experimentation and use, but it is not a causal factor. Similarly, poverty may increase susceptibility, but there is no automatic causal relationship with addiction. Many poverty-stricken communities are free of addiction <a href="/wiki/Epidemics" title="Epidemics" class="mw-redirect">epidemics</a>, as are many people with mental illness.</p>
<p>Bejerot's analysis was that the presence of five factors on their own constitutes a risk that an individual will become an addict, or that a community will be affected by an epidemic of addiction:</p>
<ul>
<li>Availability of the addictive substance</li>
<li>Money to acquire the substance</li>
<li>Time to use the substance</li>
<li>Example of use of the substance in the immediate environment</li>
<li>A permissive ideology in relation to the use of the substance. <sup id="cite_ref-13" class="reference"><a href="#cite_note-13" title=""><span>[</span>14<span>]</span></a></sup></li>
</ul>
<p>Bejerot's opinion was that drug addicts must be prosecuted. This does not mean that Bejerot proposed what he called the harsh American sentences. - The society must (in his view), however, make it very uncomfortable to abuse illicit drugs. <sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup> Drug addict should be offered treatment, mandatory if necessary, but not treatment that helped them to continue the abuse of the drug.</p>
<p><a name="Treatment" id="Treatment"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=19" title="Edit section: Treatment">edit</a>]</span> <span class="mw-headline">Treatment</span></h2>
<p>Drug addiction is a complex but treatable brain disease. It is characterized by compulsive drug craving, seeking, and use that persist even in the face of severe adverse consequences. For most people, drug addiction becomes chronic, with relapses possible even after long periods of abstinence. As a chronic, recurring illness, addiction may require continued treatments to increase the intervals between relapses and diminish their intensity. Through treatment tailored to individual needs, people with drug addiction can recover and lead productive lives. The ultimate goal of drug addiction treatment is to enable an individual to achieve lasting abstinence, but the immediate goals are to reduce drug abuse, improve the patient's ability to function, and minimize the medical and social complications of drug abuse and addiction. Like people with diabetes or heart disease, people in treatment for drug addiction will need to change behavior to adopt a more healthful lifestyle.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15" title=""><span>[</span>16<span>]</span></a></sup></p>
<p>Treatments for drug addiction vary widely according to the types of drugs involved, amount of drugs used, duration of the drug addiction, medical complications and the social needs of the individual. Determining the best type of recovery program for an addicted person depends on a number of factors, including: personality, drug(s) of addiction, concept of spirituality or religion, mental or physical illness, and local availability and affordability of programs.</p>
<p>Many different ideas circulate regarding what is considered a "successful" outcome in the recovery from addiction. It is widely accepted that abstinence from addictive substances is a successful outcome. However, abstinence is difficult to achieve in practice. Programs that emphasize controlled drinking exist for alcohol addiction. Opiate replacement therapy has been a medical standard of treatment for opioid addiction for many years.</p>
<p>Treatments and attitudes toward drug addiction vary widely among different countries. In the USA and developing countries, the goal of treatment for drug dependence is generally total abstinence from all drugs. While ideal, this is in practice very difficult to achieve. Other countries, particularly in Europe, argue the aims of treatment for drug dependence are more complex, with treatment aims including reduction in use to the point that drug use no longer interferes with normal activities such as work and family commitments, shifts the addict away from more dangerous routes of drug administration such as injecting to safer routes such as oral administration, reduction in crime committed by drug addicts, and treatment of other comorbid conditions such as AIDS, hepatitis and mental health disorders. These kind of outcomes can be achieved without eliminating drug use completely. Drug treatment programs in Europe often report more favourable outcomes than those in the USA because the criteria for measuring success are functional rather than abstinence based. <sup id="cite_ref-Ball_and_van_de_Wijngaart_16-0" class="reference"><a href="#cite_note-Ball_and_van_de_Wijngaart-16" title=""><span>[</span>17<span>]</span></a></sup><sup id="cite_ref-Reynolds_17-0" class="reference"><a href="#cite_note-Reynolds-17" title=""><span>[</span>18<span>]</span></a></sup><sup id="cite_ref-Moggi_18-0" class="reference"><a href="#cite_note-Moggi-18" title=""><span>[</span>19<span>]</span></a></sup> The supporters of programs with total abstinence from drugs as a goal stress that enabling further drug use just means prolonged drug use and risks an increase in addiction and complications from addiction. <sup id="cite_ref-19" class="reference"><a href="#cite_note-19" title=""><span>[</span>20<span>]</span></a></sup></p>
<p><a name="Residential" id="Residential"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=20" title="Edit section: Residential">edit</a>]</span> <span class="mw-headline">Residential</span></h3>
<p>Residential drug treatment can be broadly divided into two camps: 12 step programs or Therapeutic Communities. 12 step programs have the advantage of coming with an instant social support network though some find the spiritual context not to their taste. In the UK drug treatment is generally moving towards a more integrated approach with rehabs offering a variety of approaches. These other programs may use <a href="/wiki/Cognitive-Behavioral_Therapy" title="Cognitive-Behavioral Therapy" class="mw-redirect">Cognitive-Behavioral Therapy</a> an approach that looks at the relationship between thoughts feelings and behaviors, recognizing that a change in any of these areas can affect the whole. CBT sees addiction as a behavior rather than a disease and subsequently curable, or rather, unlearnable. CBT programs recognize that for some individuals controlled use is a more realistic possibility. <sup id="cite_ref-20" class="reference"><a href="#cite_note-20" title=""><span>[</span>21<span>]</span></a></sup></p>
<p><a name="12_step_program" id="12_step_program"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=21" title="Edit section: 12 step program">edit</a>]</span> <span class="mw-headline">12 step program</span></h4>
<p>One of many recovery methods is the <a href="/wiki/Twelve-step_program" title="Twelve-step program">12 step</a> recovery program, with prominent examples including <a href="/wiki/Alcoholics_Anonymous" title="Alcoholics Anonymous">Alcoholics Anonymous</a> and <a href="/wiki/Narcotics_Anonymous" title="Narcotics Anonymous">Narcotics Anonymous</a>. They are commonly known and used for a variety of addictions for the individual addicted and the family of the individual. <a href="/wiki/Substance-abuse_rehabilitation" title="Substance-abuse rehabilitation" class="mw-redirect">Substance-abuse rehabilitation</a> (or "rehab") centers frequently offer a residential treatment program for the seriously addicted in order to isolate the patient from drugs and interactions with other users and dealers. Outpatient clinics usually offer a combination of individual <a href="/wiki/Counseling" title="Counseling" class="mw-redirect">counseling</a> and group counseling. Frequently a physician or psychiatrist will assist with <a href="/wiki/Pharmacology" title="Pharmacology">prescriptions</a> the side effects of the addiction (the most common side effect that the medications can help is anxiety).</p>
<p><a name="Anti-addictive_drugs" id="Anti-addictive_drugs"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=22" title="Edit section: Anti-addictive drugs">edit</a>]</span> <span class="mw-headline">Anti-addictive drugs</span></h3>
<p>Other forms of treatment include replacement drugs such as <a href="/wiki/Methadone" title="Methadone">methadone</a> or <a href="/wiki/Buprenorphine" title="Buprenorphine">buprenorphine</a>, used as a substitute for illicit opiate drugs.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21" title=""><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-22" class="reference"><a href="#cite_note-22" title=""><span>[</span>23<span>]</span></a></sup> Although these drugs are themselves addictive, opioid dependency is so severe that a way to stabilize opioid use is required. Once stabilized, treatment enters maintenance or tapering phases. In the United States, opiate replacement therapy is tightly regulated in <a href="/wiki/Methadone_clinic" title="Methadone clinic">methadone clinics</a> and under the <a href="/wiki/DATA_2000" title="DATA 2000" class="mw-redirect">DATA 2000</a> legislation. In some countries, other opioid derivatives such as <a href="/wiki/Levomethadyl_acetate" title="Levomethadyl acetate">levomethadyl acetate</a>,<sup id="cite_ref-23" class="reference"><a href="#cite_note-23" title=""><span>[</span>24<span>]</span></a></sup> <a href="/wiki/Dihydrocodeine" title="Dihydrocodeine">dihydrocodeine</a>,<sup id="cite_ref-24" class="reference"><a href="#cite_note-24" title=""><span>[</span>25<span>]</span></a></sup> <a href="/wiki/Dihydroetorphine" title="Dihydroetorphine">dihydroetorphine</a><sup id="cite_ref-25" class="reference"><a href="#cite_note-25" title=""><span>[</span>26<span>]</span></a></sup> and even <a href="/wiki/Heroin" title="Heroin">heroin</a><sup id="cite_ref-Metrebian1_26-0" class="reference"><a href="#cite_note-Metrebian1-26" title=""><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-Metrebian2_27-0" class="reference"><a href="#cite_note-Metrebian2-27" title=""><span>[</span>28<span>]</span></a></sup> are used as substitute drugs for illegal street opiates, with different drugs being used depending on the needs of the individual patient.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28" title=""><span>[</span>29<span>]</span></a></sup></p>
<p>Substitute drugs for other forms of drug dependence have historically been less successful than opioid substitute treatment, but some limited success has been seen with drugs such as <a href="/wiki/Dexamphetamine" title="Dexamphetamine" class="mw-redirect">dexamphetamine</a> to treat stimulant addiction,<sup id="cite_ref-29" class="reference"><a href="#cite_note-29" title=""><span>[</span>30<span>]</span></a></sup><sup id="cite_ref-30" class="reference"><a href="#cite_note-30" title=""><span>[</span>31<span>]</span></a></sup> and <a href="/wiki/Clomethiazole" title="Clomethiazole">clomethiazole</a> to treat alcohol addiction.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31" title=""><span>[</span>32<span>]</span></a></sup> <a href="/wiki/Bromocriptine" title="Bromocriptine">Bromocriptine</a> and <a href="/wiki/Desipramine" title="Desipramine">desipramine</a> have been reported to be effective for treatment of cocaine but not amphetamine addiction.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32" title=""><span>[</span>33<span>]</span></a></sup></p>
<p>Other pharmacological treatments for alcohol addiction include drugs like naltrexone, <a href="/wiki/Disulfiram" title="Disulfiram">disulfiram</a>, <a href="/wiki/Acamprosate" title="Acamprosate">acamprosate</a> and <a href="/wiki/Topiramate" title="Topiramate">topiramate</a>,<sup id="cite_ref-33" class="reference"><a href="#cite_note-33" title=""><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-34" class="reference"><a href="#cite_note-34" title=""><span>[</span>35<span>]</span></a></sup> but rather than substituting for alcohol, these drugs are intended to reduce the desire to drink, either by directly reducing cravings as with acamprosate and topiramate, or by producing unpleasant effects when alcohol is consumed, as with disulfiram. These drugs can be effective if treatment is maintained, but compliance can be an issue as alcoholic patients often forget to take their medication, or discontinue use because of excessive side effects.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35" title=""><span>[</span>36<span>]</span></a></sup><sup id="cite_ref-36" class="reference"><a href="#cite_note-36" title=""><span>[</span>37<span>]</span></a></sup> Additional drugs acting on <a href="/wiki/Glutamate" title="Glutamate" class="mw-redirect">glutamate</a> neurotransmission such as <a href="/wiki/Modafinil" title="Modafinil">modafinil</a>, <a href="/wiki/Lamotrigine" title="Lamotrigine">lamotrigine</a>, <a href="/wiki/Gabapentin" title="Gabapentin">gabapentin</a> and <a href="/wiki/Memantine" title="Memantine">memantine</a> have also been proposed for use in treating addiction to alcohol and other drugs.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37" title=""><span>[</span>38<span>]</span></a></sup></p>
<p>Opioid antagonists such as <a href="/wiki/Naltrexone" title="Naltrexone">naltrexone</a> and <a href="/wiki/Nalmefene" title="Nalmefene">nalmefene</a> have also been used successfully in the treatment of alcohol addiction,<sup id="cite_ref-38" class="reference"><a href="#cite_note-38" title=""><span>[</span>39<span>]</span></a></sup><sup id="cite_ref-39" class="reference"><a href="#cite_note-39" title=""><span>[</span>40<span>]</span></a></sup> which is often particularly challenging to treat. These drugs have also been used to a lesser extent for long-term maintenance treatment of former opiate addicts, but cannot be started until the patient has been abstinent for an extended period, otherwise they can trigger acute opioid withdrawal symptoms.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40" title=""><span>[</span>41<span>]</span></a></sup></p>
<p>Treatment of <a href="/wiki/Stimulant" title="Stimulant">stimulant</a> addiction can often be difficult, with substitute drugs often being ineffective, although newer drugs such as <a href="/wiki/Nocaine" title="Nocaine">nocaine</a>, <a href="/wiki/Vanoxerine" title="Vanoxerine">vanoxerine</a> and <a href="/wiki/Modafinil" title="Modafinil">modafinil</a> may have more promise in this area, as well as the GABA<sub>B</sub> agonist <a href="/wiki/Baclofen" title="Baclofen">baclofen</a>.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41" title=""><span>[</span>42<span>]</span></a></sup><sup id="cite_ref-42" class="reference"><a href="#cite_note-42" title=""><span>[</span>43<span>]</span></a></sup> Another strategy that has recently been successfully trialled used a combination of the <a href="/wiki/Benzodiazepine" title="Benzodiazepine">benzodiazepine</a> antagonist <a href="/wiki/Flumazenil" title="Flumazenil">flumazenil</a> with <a href="/wiki/Hydroxyzine" title="Hydroxyzine">hydroxyzine</a> and <a href="/wiki/Gabapentin" title="Gabapentin">gabapentin</a> for the treatment of <a href="/wiki/Methamphetamine" title="Methamphetamine">methamphetamine</a> addiction.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43" title=""><span>[</span>44<span>]</span></a></sup></p>
<p>Another area in which drug treatment has been widely used is in the treatment of <a href="/wiki/Nicotine" title="Nicotine">nicotine</a> addiction. Various drugs have been used for this purpose such as <a href="/wiki/Bupropion" title="Bupropion">bupropion</a>, <a href="/wiki/Mecamylamine" title="Mecamylamine">mecamylamine</a> and the more recently developed <a href="/wiki/Varenicline" title="Varenicline">varenicline</a>. The cannaboinoid antagonist <a href="/wiki/Rimonabant" title="Rimonabant">rimonabant</a> has also been trialled for treatment of nicotine addiction but has not been widely adopted for this purpose.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44" title=""><span>[</span>45<span>]</span></a></sup><sup id="cite_ref-45" class="reference"><a href="#cite_note-45" title=""><span>[</span>46<span>]</span></a></sup><sup id="cite_ref-46" class="reference"><a href="#cite_note-46" title=""><span>[</span>47<span>]</span></a></sup></p>
<p><a href="/wiki/Ibogaine" title="Ibogaine">Ibogaine</a> is a psychoactive drug that specifically interrupts the addictive response, and is currently being studied for its effects upon cocaine, heroin, nicotine, and SSRI addicts. Alternative medicine clinics offering ibogaine treatment have appeared along the U.S. border.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47" title=""><span>[</span>48<span>]</span></a></sup> A synthetic analogue of ibogaine, <a href="/wiki/18-methoxycoronaridine" title="18-methoxycoronaridine" class="mw-redirect">18-methoxycoronaridine</a> has also been developed which has similar efficacy but less side effects, however this drug is still being tested in animals and human trials have not yet been carried out.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48" title=""><span>[</span>49<span>]</span></a></sup><sup id="cite_ref-49" class="reference"><a href="#cite_note-49" title=""><span>[</span>50<span>]</span></a></sup></p>
<p><a name="Alternative_therapies" id="Alternative_therapies"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=23" title="Edit section: Alternative therapies">edit</a>]</span> <span class="mw-headline">Alternative therapies</span></h3>
<p>Alternative therapies, such as <a href="/wiki/Acupuncture" title="Acupuncture">acupuncture</a>, are used by some practitioners to alleviate the symptoms of drug addiction. In 1997, the American Medical Association (AMA) adopted as policy the following statement after a report on a number of alternative therapies including acupuncture:</p>
<blockquote>
<p>There is little evidence to confirm the safety or efficacy of most alternative therapies. Much of the information currently known about these therapies makes it clear that many have not been shown to be efficacious. Well-designed, stringently controlled research should be done to evaluate the efficacy of alternative therapies.</p>
</blockquote>
<p>Acupuncture has been shown to be no more effective than control treatments in the treatment of opiate dependence.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50" title=""><span>[</span>51<span>]</span></a></sup> Acupuncture, <a href="/wiki/Acupressure" title="Acupressure">acupressure</a>, <a href="/w/index.php?title=Laser_therapy&amp;action=edit&amp;redlink=1" class="new" title="Laser therapy (page does not exist)">laser therapy</a> and <a href="/wiki/Electrostimulation" title="Electrostimulation" class="mw-redirect">electrostimulation</a> have no demonstrated efficacy for smoking cessation.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51" title=""><span>[</span>52<span>]</span></a></sup></p>
<p><a name="Medical_definitions" id="Medical_definitions"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=24" title="Edit section: Medical definitions">edit</a>]</span> <span class="mw-headline">Medical definitions</span></h2>
<p>The terms <i>abuse</i> and <i>addiction</i> have been defined and re-defined over the years. The 1957 <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO) Expert Committee on Addiction-Producing Drugs defined addiction and habituation as components of <a href="/wiki/Drug_abuse" title="Drug abuse">drug abuse</a>:</p>
<blockquote>
<p><i><b>Drug addiction</b> is a state of periodic or chronic intoxication produced by the repeated consumption of a drug (natural or synthetic). Its characteristics include: (i) an overpowering desire or need (compulsion) to continue taking the drug and to obtain it by any means; (ii) a tendency to increase the dose; (iii) a psychic (psychological) and generally a <a href="/wiki/Physical_dependence" title="Physical dependence">physical dependence</a> on the effects of the drug; and (iv) detrimental effects on the individual and on society.</i></p>
</blockquote>
<blockquote>
<p><i><a href="/w/index.php?title=Drug_habituation&amp;action=edit&amp;redlink=1" class="new" title="Drug habituation (page does not exist)">Drug habituation</a> (habit) is a condition resulting from the repeated consumption of a drug. Its characteristics include (i) a desire (but not a compulsion) to continue taking the drug for the sense of improved well-being which it engenders; (ii) little or no tendency to increase the dose; (iii) some degree of psychic dependence on the effect of the drug, but absence of physical dependence and hence of an abstinence syndrome [withdrawal], and (iv) detrimental effects, if any, primarily on the individual.</i></p>
</blockquote>
<p>In 1964, a new WHO committee found these definitions to be inadequate, and suggested using the blanket term "drug dependence":</p>
<blockquote>
<p><i>The definition of addiction gained some acceptance, but confusion in the use of the terms addiction and habituation and misuse of the former continued. Further, the list of drugs abused increased in number and diversity. These difficulties have become increasingly apparent and various attempts have been made to find a term that could be applied to drug abuse generally. The component in common appears to be dependence, whether psychic or physical or both. Hence, use of the term 'drug dependence', with a modifying phase linking it to a particular drug type in order to differentiate one class of drugs from another, had been given most careful consideration. The Expert Committee recommends substitution of the term 'drug dependence' for the terms 'drug addiction' and 'drug habituation'.</i></p>
</blockquote>
<p>The committee did not clearly define dependence, but did go on to clarify that there was a distinction between physical and psychological ("psychic") dependence. It said that drug abuse was "<i>a state of psychic dependence or physical dependence, or both, on a drug, arising in a person following administration of that drug on a periodic or continued basis.</i>" Psychic dependence was defined as a state in which "<i>there is a feeling of satisfaction and psychic drive that requires periodic or continuous administration of the drug to produce pleasure or to avoid discomfort</i>" and all drugs were said to be capable of producing this state:</p>
<blockquote>
<p><i>There is scarcely any agent which can be taken into the body to which some individuals will not get a reaction satisfactory or pleasurable to them, persuading them to continue its use even to the point of abuse&#160;— that is, to excessive or persistent use beyond medical need.</i></p>
</blockquote>
<p>The 1957 and 1964 definitions of addiction, dependence and abuse persist to the present day in medical literature. It should be noted that at this time (2006) the Diagnostic Statistical Manual (DSM IVR) now spells out specific criteria for defining abuse and dependence. (DSM IVR) uses the term substance dependence instead of <i>addiction</i>; a maladaptive pattern of substance abuse, leading to clinically significant impairment or distress, as manifested by three (or more) specified criteria, occurring at any time in the same 12-month period. This definition is also applicable on drugs with smaller or nonexistent physical signs of withdrawal, for ex. cannabis.</p>
<p>In 2001, the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine jointly issued "Definitions Related to the Use of Opioids for the Treatment of Pain," which defined the following terms:<sup id="cite_ref-painmed_2-1" class="reference"><a href="#cite_note-painmed-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<blockquote>
<p><i><b>Addiction</b> is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. It is characterized by behaviors that include one or more of the following: impaired control over drug use, compulsive use, continued use despite harm, and craving.</i></p>
<blockquote>
<p><i><a href="/wiki/Physical_dependence" title="Physical dependence">Physical dependence</a> is a state of adaptation that is manifested by a drug class specific withdrawal syndrome that can be produced by abrupt cessation, rapid dose reduction, decreasing blood level of the drug, and/or administration of an antagonist.</i></p>
</blockquote>
<blockquote>
<p><i><a href="/wiki/Drug_tolerance" title="Drug tolerance">Tolerance</a> is the body's physical adaptation to a drug: greater amounts of the drug are required over time to achieve the initial effect as the body "gets used to" and adapts to the intake.</i></p>
</blockquote>
<blockquote>
<p><i><b>Pseudo addiction</b> is a term which has been used to describe patient behaviors that may occur when pain is undertreated. Patients with unrelieved pain may become focused on obtaining medications, may “clock watch,” and may otherwise seem inappropriately “drug seeking.” Even such behaviors as illicit drug use and deception can occur in the patient's efforts to obtain relief. Pseudoaddiction can be distinguished from true addiction in that the behaviors resolve when pain is effectively treated.</i></p>
</blockquote>
</blockquote>
<p>The <a href="/wiki/Diagnostic_and_Statistical_Manual_of_Mental_Disorders" title="Diagnostic and Statistical Manual of Mental Disorders">Diagnostic and Statistical Manual of Mental Disorders</a>, <b>DSM-IV-TR</b> doesn’t use the word <b>addiction</b> at all. Instead it has a section about <a href="/wiki/Substance_dependence" title="Substance dependence">Substance dependence</a></p>
<blockquote>
<p><i>"When an individual persists in use of alcohol or other drugs despite problems related to use of the substance, <a href="/wiki/Substance_dependence" title="Substance dependence">substance dependence</a> may be diagnosed. Compulsive and repetitive use may result in tolerance to the effect of the drug and withdrawal symptoms when use is reduced or stopped. This, along with <a href="/wiki/Substance_Abuse" title="Substance Abuse">Substance Abuse</a> are considered Substance Use Disorders...."</i> <sup id="cite_ref-DSM4_52-0" class="reference"><a href="#cite_note-DSM4-52" title=""><span>[</span>53<span>]</span></a></sup></p>
</blockquote>
<p>A definition of <b>addiction</b> proposed by professor <a href="/wiki/Nils_Bejerot" title="Nils Bejerot">Nils Bejerot</a>:</p>
<blockquote>
<p><i>"An emotional fixation (sentiment) acquired through learning, which intermittently or continually expresses itself in purposeful, stereotyped behavior with the character and force of a natural drive, aiming at a specific pleasure or the avoidance of a specific discomfort."</i><sup id="cite_ref-NIDA_53-0" class="reference"><a href="#cite_note-NIDA-53" title=""><span>[</span>54<span>]</span></a></sup></p>
</blockquote>
<p><a name="Addiction_and_drug_control_legislation" id="Addiction_and_drug_control_legislation"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=25" title="Edit section: Addiction and drug control legislation">edit</a>]</span> <span class="mw-headline">Addiction and drug control legislation</span></h2>
<p>Depending on the jurisdiction, addictive drugs may be legal only as part of a government sponsored study, illegal to use for any purpose, illegal to sell, or even illegal to merely possess.</p>
<p>Most countries have legislation which brings various drugs and drug-like <a href="/wiki/Chemical_substance" title="Chemical substance">substances</a> under the control of licensing systems. Typically this legislation covers any or all of the opiates, amphetamines, cannabinoids, cocaine, barbiturates, hallucinogenics and a variety of more modern synthetic drugs. Unlicensed production, supply or possession is a criminal offence.</p>
<p>Usually, however, drug classification under such legislation is not related simply to addictiveness. The substances covered often have very different addictive properties. Some are highly prone to cause physical dependency, whilst others rarely cause any form of compulsive need whatsoever. Also, under legislation specifically about drugs, <a href="/wiki/Alcohol" title="Alcohol">alcohol</a> is not usually included.</p>
<p>Although the legislation may be justifiable on moral or public health grounds, it can make addiction or dependency a much more serious issue for the individual: reliable supplies of a drug become difficult to secure, and the individual becomes vulnerable to both criminal abuse and legal punishment.</p>
<p>It is unclear whether laws against drugs do anything to stem usage and dependency. In jurisdictions where addictive drugs are illegal, they are generally supplied by <a href="/wiki/Drug_dealer" title="Drug dealer" class="mw-redirect">drug dealers</a>, who are often involved with <a href="/wiki/Organized_crime" title="Organized crime">organized crime</a>. Even though the cost of producing most illegal addictive substances is very low, their illegality combined with the addict's need permits the seller to command a premium price, often hundreds of times the production cost. As a result, the addict sometimes turns to crime to support their habit.</p>
<p><a name="History_of_addiction" id="History_of_addiction"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=26" title="Edit section: History of addiction">edit</a>]</span> <span class="mw-headline">History of addiction</span></h2>
<table class="metadata plainlinks ambox ambox-content" style="">
<tr>
<td class="mbox-image">
<div style="width: 52px;"><a href="/wiki/File:Question_book-new.svg" class="image" title="Question book-new.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" width="50" height="39" border="0" /></a></div>
</td>
<td class="mbox-text" style="">This section <b>needs additional <a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources">citations</a> for <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">verification</a>.</b> Please help <a href="http://en.wikipedia.org/w/index.php?title=Drug_addiction&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Drug_addiction&amp;action=edit" rel="nofollow">improve this article</a> by adding <a href="/wiki/Wikipedia:Reliable_sources" title="Wikipedia:Reliable sources">reliable references</a> (ideally, using <i><a href="/wiki/Wikipedia:Footnotes" title="Wikipedia:Footnotes">inline citations</a></i>). Unsourced material may be <a href="/wiki/Template:Fact" title="Template:Fact">challenged</a> and <a href="/wiki/Wikipedia:BURDEN" title="Wikipedia:BURDEN" class="mw-redirect">removed</a>. <small><i>(September 2007)</i></small></td>
</tr>
</table>
<p>The <a href="/wiki/Phenomenon" title="Phenomenon">phenomenon</a> of drug <a href="/wiki/Addiction" title="Addiction">addiction</a> has occurred to some degree throughout recorded <a href="/wiki/History" title="History">history</a> (see "<a href="/wiki/Opium" title="Opium">opium</a>"). Modern <a href="/wiki/Agriculture" title="Agriculture">agricultural</a> practices, improvements in access to drugs, advancements in <a href="/wiki/Biochemistry" title="Biochemistry">biochemistry</a>, and dramatic increases in the recommendation of drug usage by clinical practitioners have exacerbated the problem significantly in the 20th century. Improved means of active biological agent manufacture and the introduction of synthetic compounds, such as <a href="/wiki/Methamphetamine" title="Methamphetamine">methamphetamine</a> are also factors contributing to drug addiction.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54" title=""><span>[</span>55<span>]</span></a></sup></p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=27" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<table cellspacing="0" cellpadding="0" class="multicol" style="background:transparent; width:100%;">
<tr>
<td width="50%" align="left" valign="top">
<ul>
<li><a href="/wiki/Addiction" title="Addiction">Addiction</a></li>
<li><a href="/wiki/Addiction_recovery_groups" title="Addiction recovery groups">Addiction recovery groups</a></li>
<li><a href="/wiki/Alcoholism" title="Alcoholism">Alcoholism</a></li>
<li><a href="/wiki/Arguments_for_and_against_drug_prohibition" title="Arguments for and against drug prohibition">Arguments for and against drug prohibition</a></li>
<li><a href="/wiki/Cocaine_dependence" title="Cocaine dependence">Cocaine dependence</a></li>
<li><a href="/wiki/Demand_reduction" title="Demand reduction">Demand reduction</a></li>
<li><a href="/wiki/Drug_abuse" title="Drug abuse">Drug abuse</a></li>
<li><a href="/wiki/Drug_policy" title="Drug policy">Drug policy</a></li>
<li><a href="/wiki/Drugs_and_prostitution" title="Drugs and prostitution">Drugs and prostitution</a></li>
<li><a href="/wiki/Poly_drug_use" title="Poly drug use">Poly drug use</a></li>
<li><a href="/wiki/Drug_tolerance" title="Drug tolerance">Drug tolerance</a></li>
<li><a href="/wiki/Drug_Intervention_Program" title="Drug Intervention Program" class="mw-redirect">Drug Intervention Program</a></li>
</ul>
</td>
<td width="50%" align="left" valign="top">
<ul>
<li><a href="/wiki/DSM-IV_Codes" title="DSM-IV Codes">DSM-IV Codes</a></li>
<li><a href="/wiki/Harm_reduction" title="Harm reduction">Harm reduction</a></li>
<li><a href="/wiki/Nils_Bejerot" title="Nils Bejerot">Nils Bejerot</a></li>
<li><a href="/wiki/Physical_dependence" title="Physical dependence">Physical dependence</a></li>
<li><a href="/wiki/Psychoactive_drug" title="Psychoactive drug">Psychoactive drug</a></li>
<li><a href="/wiki/Tachyphylaxis" title="Tachyphylaxis">Tachyphylaxis</a></li>
<li><a href="/wiki/Treatment_Improvement_Protocols" title="Treatment Improvement Protocols">Treatment Improvement Protocols</a></li>
<li><a href="/wiki/Rat_Park" title="Rat Park">Rat Park</a></li>
<li><a href="/wiki/Rational_addiction" title="Rational addiction">Rational addiction</a></li>
<li><i><a href="/wiki/Robinson_v._California" title="Robinson v. California">Robinson v. California</a></i> (1964), decision by the <a href="/wiki/U.S._Supreme_Court" title="U.S. Supreme Court" class="mw-redirect">U.S. Supreme Court</a> that states cannot criminalize narcotics addiction itself</li>
<li><a href="/wiki/Substance_dependence" title="Substance dependence">Substance dependence</a></li>
<li><a href="/wiki/Self-medication" title="Self-medication">Self-medication</a></li>
<li><a href="/wiki/Withdrawal" title="Withdrawal">withdrawal</a></li>
</ul>
</td>
</tr>
</table>
<p><a name="Literature" id="Literature"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=28" title="Edit section: Literature">edit</a>]</span> <span class="mw-headline">Literature</span></h2>
<ul>
<li>Sainsbury, <i>Drug and the Drug Habit</i> (New York, 1909)</li>
<li>C. A. McBride, <i>Modern Treatment of Alcoholism and Drug Narcotism</i> (New York, 1910)</li>
<li>G. E. Pettey, <i>Narcotic Drug Diseases and Allied Ailments</i> (Philadelphia, 1913)</li>
<li><a href="/wiki/Fitz_Hugh_Ludlow" title="Fitz Hugh Ludlow">Fitz Hugh Ludlow</a> wrote <i>The Hasheesh Eater</i> (1857) and <i>The Opium Habit</i> (1868), designed as a warning.</li>
<li><a href="/wiki/Thomas_de_Quincey" title="Thomas de Quincey">Thomas de Quincey</a>, <i>Confessions of an English Opium Eater</i> (London, 1822)</li>
<li><a href="/wiki/William_S._Burroughs" title="William S. Burroughs">William S. Burroughs</a>, <i>Junkie</i> (New York, 1953)</li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=29" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-Nutt-0"><b><a href="#cite_ref-Nutt_0-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNutt_D.2C_King_LA.2C_Saulsbury_W.2C_Blakemore_C2007">Nutt D, King LA, Saulsbury W, Blakemore C (2007). "Development of a rational scale to assess the harm of drugs of potential misue". <i>Lancet</i> <b>369</b> (9566): 1047–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2807%2960464-4" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2807%2960464-4" rel="nofollow">10.1016/S0140-6736(07)60464-4</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17382831" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17382831">PMID 17382831</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Development+of+a+rational+scale+to+assess+the+harm+of+drugs+of+potential+misue&amp;rft.jtitle=Lancet&amp;rft.aulast=Nutt+D%2C+King+LA%2C+Saulsbury+W%2C+Blakemore+C&amp;rft.au=Nutt+D%2C+King+LA%2C+Saulsbury+W%2C+Blakemore+C&amp;rft.date=2007&amp;rft.volume=369&amp;rft.issue=9566&amp;rft.pages=1047%E2%80%9353&amp;rft_id=info:doi/10.1016%2FS0140-6736%2807%2960464-4&amp;rft_id=info:pmid/17382831&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Koob_and_Kreek-1">^ <a href="#cite_ref-Koob_and_Kreek_1-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Koob_and_Kreek_1-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Koob_and_Kreek_1-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Koob_and_Kreek_1-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Koob_and_Kreek_1-4" title=""><sup><i><b>e</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFKoob_G.2C_Kreek_MJ2007">Koob G, Kreek MJ (2007). "Stress, dysregulation of drug reward pathways, and the transition to drug dependence". <i>Am J Psychiatry</i> <b>164</b> (8): 1149–59. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.2007.05030503" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.2007.05030503" rel="nofollow">10.1176/appi.ajp.2007.05030503</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17671276" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17671276">PMID 17671276</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Stress%2C+dysregulation+of+drug+reward+pathways%2C+and+the+transition+to+drug+dependence&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Koob+G%2C+Kreek+MJ&amp;rft.au=Koob+G%2C+Kreek+MJ&amp;rft.date=2007&amp;rft.volume=164&amp;rft.issue=8&amp;rft.pages=1149%E2%80%9359&amp;rft_id=info:doi/10.1176%2Fappi.ajp.2007.05030503&amp;rft_id=info:pmid/17671276&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-painmed-2">^ <a href="#cite_ref-painmed_2-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-painmed_2-1" title=""><sup><i><b>b</b></i></sup></a> <a href="http://www.painmed.org/pdf/definition.pdf" class="external text" title="http://www.painmed.org/pdf/definition.pdf" rel="nofollow">2001 "Definitions Related to the Use of Opioids for the Treatment of Pain,"</a>, the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine</li>
<li id="cite_note-Kalivas_and_Volkow-3">^ <a href="#cite_ref-Kalivas_and_Volkow_3-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kalivas_and_Volkow_3-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Kalivas_and_Volkow_3-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Kalivas_and_Volkow_3-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Kalivas_and_Volkow_3-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Kalivas_and_Volkow_3-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Kalivas_and_Volkow_3-6" title=""><sup><i><b>g</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFKalivas_PW.2C_Volkow_ND2005">Kalivas PW, Volkow ND (2005). "The neural basis of addiction: a pathology of motivation and choice". <i>Am J Psychiatry</i> <b>162</b> (8): 1403–13. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.162.8.1403" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.162.8.1403" rel="nofollow">10.1176/appi.ajp.162.8.1403</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16055761" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16055761">PMID 16055761</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+neural+basis+of+addiction%3A+a+pathology+of+motivation+and+choice&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Kalivas+PW%2C+Volkow+ND&amp;rft.au=Kalivas+PW%2C+Volkow+ND&amp;rft.date=2005&amp;rft.volume=162&amp;rft.issue=8&amp;rft.pages=1403%E2%80%9313&amp;rft_id=info:doi/10.1176%2Fappi.ajp.162.8.1403&amp;rft_id=info:pmid/16055761&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Jones_and_Bonci-4">^ <a href="#cite_ref-Jones_and_Bonci_4-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Jones_and_Bonci_4-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Jones_and_Bonci_4-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Jones_and_Bonci_4-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Jones_and_Bonci_4-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Jones_and_Bonci_4-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Jones_and_Bonci_4-6" title=""><sup><i><b>g</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFJones_S.2C_Bonci_A2005">Jones S, Bonci A (2005). "Synaptic plasticity and drug addiction". <i>Curr Opin Pharmacol</i> <b>5</b> (1): 20–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.coph.2004.08.011" class="external text" title="http://dx.doi.org/10.1016%2Fj.coph.2004.08.011" rel="nofollow">10.1016/j.coph.2004.08.011</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15661621" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15661621">PMID 15661621</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Synaptic+plasticity+and+drug+addiction&amp;rft.jtitle=Curr+Opin+Pharmacol&amp;rft.aulast=Jones+S%2C+Bonci+A&amp;rft.au=Jones+S%2C+Bonci+A&amp;rft.date=2005&amp;rft.volume=5&amp;rft.issue=1&amp;rft.pages=20%E2%80%935&amp;rft_id=info:doi/10.1016%2Fj.coph.2004.08.011&amp;rft_id=info:pmid/15661621&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Eisch_and_Harburg-5">^ <a href="#cite_ref-Eisch_and_Harburg_5-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Eisch_and_Harburg_5-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Eisch_and_Harburg_5-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFEisch_AJ.2C_Harburg_GC2006">Eisch AJ, Harburg GC (2006). "Opiates, psychostimulants, and adult hippocampal neurogenesis: Insights for addiction and stem cell biology". <i>Hippocampus</i> <b>16</b> (3): 271–86. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fhipo.20161" class="external text" title="http://dx.doi.org/10.1002%2Fhipo.20161" rel="nofollow">10.1002/hipo.20161</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16411230" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16411230">PMID 16411230</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Opiates%2C+psychostimulants%2C+and+adult+hippocampal+neurogenesis%3A+Insights+for+addiction+and+stem+cell+biology&amp;rft.jtitle=Hippocampus&amp;rft.aulast=Eisch+AJ%2C+Harburg+GC&amp;rft.au=Eisch+AJ%2C+Harburg+GC&amp;rft.date=2006&amp;rft.volume=16&amp;rft.issue=3&amp;rft.pages=271%E2%80%9386&amp;rft_id=info:doi/10.1002%2Fhipo.20161&amp;rft_id=info:pmid/16411230&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Rang-6"><b><a href="#cite_ref-Rang_6-0" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFRang.2C_H._P.2003">Rang, H. P. (2003). <i>Pharmacology</i>. Edinburgh: Churchill Livingstone. pp.&#160;596. <a href="/wiki/Special:BookSources/0443071454" class="internal">ISBN 0-443-07145-4</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pharmacology&amp;rft.aulast=Rang%2C+H.+P.&amp;rft.au=Rang%2C+H.+P.&amp;rft.date=2003&amp;rft.pages=pp.%26nbsp%3B596&amp;rft.place=Edinburgh&amp;rft.pub=Churchill+Livingstone&amp;rft.isbn=0-443-07145-4&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Kourrich-7">^ <a href="#cite_ref-Kourrich_7-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kourrich_7-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFKourrich_S.2C_Rothwell_PE.2C_Klug_JR.2C_Thomas_MJ2007">Kourrich S, Rothwell PE, Klug JR, Thomas MJ (2007). "Cocaine experience controls bidirectional synaptic plasticity in the nucleus accumbens". <i>J. Neurosci.</i> <b>27</b> (30): 7921–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1523%2FJNEUROSCI.1859-07.2007" class="external text" title="http://dx.doi.org/10.1523%2FJNEUROSCI.1859-07.2007" rel="nofollow">10.1523/JNEUROSCI.1859-07.2007</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17652583" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17652583">PMID 17652583</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cocaine+experience+controls+bidirectional+synaptic+plasticity+in+the+nucleus+accumbens&amp;rft.jtitle=J.+Neurosci.&amp;rft.aulast=Kourrich+S%2C+Rothwell+PE%2C+Klug+JR%2C+Thomas+MJ&amp;rft.au=Kourrich+S%2C+Rothwell+PE%2C+Klug+JR%2C+Thomas+MJ&amp;rft.date=2007&amp;rft.volume=27&amp;rft.issue=30&amp;rft.pages=7921%E2%80%938&amp;rft_id=info:doi/10.1523%2FJNEUROSCI.1859-07.2007&amp;rft_id=info:pmid/17652583&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Floresco-8">^ <a href="#cite_ref-Floresco_8-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Floresco_8-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFFloresco_SB.2C_Ghods-Sharifi_S2007">Floresco SB, Ghods-Sharifi S (2007). "Amygdala-prefrontal cortical circuitry regulates effort-based decision making". <i>Cereb. Cortex</i> <b>17</b> (2): 251–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Fcercor%2Fbhj143" class="external text" title="http://dx.doi.org/10.1093%2Fcercor%2Fbhj143" rel="nofollow">10.1093/cercor/bhj143</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16495432" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16495432">PMID 16495432</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Amygdala-prefrontal+cortical+circuitry+regulates+effort-based+decision+making&amp;rft.jtitle=Cereb.+Cortex&amp;rft.aulast=Floresco+SB%2C+Ghods-Sharifi+S&amp;rft.au=Floresco+SB%2C+Ghods-Sharifi+S&amp;rft.date=2007&amp;rft.volume=17&amp;rft.issue=2&amp;rft.pages=251%E2%80%9360&amp;rft_id=info:doi/10.1093%2Fcercor%2Fbhj143&amp;rft_id=info:pmid/16495432&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-9"><b><a href="#cite_ref-9" title="">^</a></b> AJ Giannini. Drug abuse and depression: Catecholamine depletion suggested as biological tie between cocaine withdrawal and depression. National Institute of Drug Abuse Notes. 2(2)5, 1987.</li>
<li id="cite_note-Bahi_and_Dreyer-10"><b><a href="#cite_ref-Bahi_and_Dreyer_10-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBahi_A.2C_Dreyer_JL2005">Bahi A, Dreyer JL (2005). "Cocaine-induced expression changes of axon guidance molecules in the adult rat brain". <i>Mol. Cell. Neurosci.</i> <b>28</b> (2): 275–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.mcn.2004.09.011" class="external text" title="http://dx.doi.org/10.1016%2Fj.mcn.2004.09.011" rel="nofollow">10.1016/j.mcn.2004.09.011</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15691709" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15691709">PMID 15691709</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cocaine-induced+expression+changes+of+axon+guidance+molecules+in+the+adult+rat+brain&amp;rft.jtitle=Mol.+Cell.+Neurosci.&amp;rft.aulast=Bahi+A%2C+Dreyer+JL&amp;rft.au=Bahi+A%2C+Dreyer+JL&amp;rft.date=2005&amp;rft.volume=28&amp;rft.issue=2&amp;rft.pages=275%E2%80%9391&amp;rft_id=info:doi/10.1016%2Fj.mcn.2004.09.011&amp;rft_id=info:pmid/15691709&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-11"><b><a href="#cite_ref-11" title="">^</a></b> AJ Giannini. RQ Quinones, DM Martin. Role of beta-endorphin and cAMP in addiction and mania. Society for Neuroscience Abstracts.15:149,1998.</li>
<li id="cite_note-12"><b><a href="#cite_ref-12" title="">^</a></b> NS Miller, AJ Giannini. The disease model of addiction. Journal of Psychoactive Drugs.22(1):83-85,1990</li>
<li id="cite_note-13"><b><a href="#cite_ref-13" title="">^</a></b> <a href="http://www.theaustralian.news.com.au/story/0,25197,23299086-5013477,00.html" class="external text" title="http://www.theaustralian.news.com.au/story/0,25197,23299086-5013477,00.html" rel="nofollow">Noel Pearson: Agendas of addiction, 2008</a></li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> <a href="http://www.rns.se/swedish-addiction.asp" class="external text" title="http://www.rns.se/swedish-addiction.asp" rel="nofollow">Nils Bejerot: Swedish addiction epidemic in an international perspective, 1988</a></li>
<li id="cite_note-15"><b><a href="#cite_ref-15" title="">^</a></b> <a href="http://www.nida.nih.gov/Infofacts/treatmeth.html" class="external text" title="http://www.nida.nih.gov/Infofacts/treatmeth.html" rel="nofollow">InfoFacts - Treatment Approaches for Drug Addiction</a></li>
<li id="cite_note-Ball_and_van_de_Wijngaart-16"><b><a href="#cite_ref-Ball_and_van_de_Wijngaart_16-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBall_JC.2C_van_de_Wijngaart_GF1994">Ball JC, van de Wijngaart GF (1994). "A Dutch addict's view of methadone maintenance--an American and a Dutch appraisal". <i><a href="/wiki/Addiction_(journal)" title="Addiction (journal)">Addiction</a></i> <b>89</b> (7): 799–802; discussion 803–14. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1360-0443.1994.tb00974.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1360-0443.1994.tb00974.x" rel="nofollow">10.1111/j.1360-0443.1994.tb00974.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8081178" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8081178">PMID 8081178</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+Dutch+addict%27s+view+of+methadone+maintenance--an+American+and+a+Dutch+appraisal&amp;rft.jtitle=%5B%5BAddiction+%28journal%29%7CAddiction%5D%5D&amp;rft.aulast=Ball+JC%2C+van+de+Wijngaart+GF&amp;rft.au=Ball+JC%2C+van+de+Wijngaart+GF&amp;rft.date=1994&amp;rft.volume=89&amp;rft.issue=7&amp;rft.pages=799%E2%80%93802%3B+discussion+803%E2%80%9314&amp;rft_id=info:doi/10.1111%2Fj.1360-0443.1994.tb00974.x&amp;rft_id=info:pmid/8081178&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Reynolds-17"><b><a href="#cite_ref-Reynolds_17-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFReynolds_M.2C_Mezey_G.2C_Chapman_M.2C_Wheeler_M.2C_Drummond_C.2C_Baldacchino_A2005">Reynolds M, Mezey G, Chapman M, Wheeler M, Drummond C, Baldacchino A (2005). "Co-morbid post-traumatic stress disorder in a substance misusing clinical population". <i>Drug Alcohol Depend</i> <b>77</b> (3): 251–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.drugalcdep.2004.08.017" class="external text" title="http://dx.doi.org/10.1016%2Fj.drugalcdep.2004.08.017" rel="nofollow">10.1016/j.drugalcdep.2004.08.017</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15734225" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15734225">PMID 15734225</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Co-morbid+post-traumatic+stress+disorder+in+a+substance+misusing+clinical+population&amp;rft.jtitle=Drug+Alcohol+Depend&amp;rft.aulast=Reynolds+M%2C+Mezey+G%2C+Chapman+M%2C+Wheeler+M%2C+Drummond+C%2C+Baldacchino+A&amp;rft.au=Reynolds+M%2C+Mezey+G%2C+Chapman+M%2C+Wheeler+M%2C+Drummond+C%2C+Baldacchino+A&amp;rft.date=2005&amp;rft.volume=77&amp;rft.issue=3&amp;rft.pages=251%E2%80%938&amp;rft_id=info:doi/10.1016%2Fj.drugalcdep.2004.08.017&amp;rft_id=info:pmid/15734225&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Moggi-18"><b><a href="#cite_ref-Moggi_18-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMoggi_F.2C_Giovanoli_A.2C_Strik_W.2C_Moos_BS.2C_Moos_RH2007">Moggi F, Giovanoli A, Strik W, Moos BS, Moos RH (2007). "Substance use disorder treatment programs in Switzerland and the USA: Program characteristics and 1-year outcomes". <i>Drug Alcohol Depend</i> <b>86</b> (1): 75–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.drugalcdep.2006.05.017" class="external text" title="http://dx.doi.org/10.1016%2Fj.drugalcdep.2006.05.017" rel="nofollow">10.1016/j.drugalcdep.2006.05.017</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16782286" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16782286">PMID 16782286</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Substance+use+disorder+treatment+programs+in+Switzerland+and+the+USA%3A+Program+characteristics+and+1-year+outcomes&amp;rft.jtitle=Drug+Alcohol+Depend&amp;rft.aulast=Moggi+F%2C+Giovanoli+A%2C+Strik+W%2C+Moos+BS%2C+Moos+RH&amp;rft.au=Moggi+F%2C+Giovanoli+A%2C+Strik+W%2C+Moos+BS%2C+Moos+RH&amp;rft.date=2007&amp;rft.volume=86&amp;rft.issue=1&amp;rft.pages=75%E2%80%9383&amp;rft_id=info:doi/10.1016%2Fj.drugalcdep.2006.05.017&amp;rft_id=info:pmid/16782286&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-19"><b><a href="#cite_ref-19" title="">^</a></b> {<a href="http://www.rns.se/swedish-addiction.asp" class="external free" title="http://www.rns.se/swedish-addiction.asp" rel="nofollow">http://www.rns.se/swedish-addiction.asp</a> Nils Bejerot: The Swedish Addiction Epidemic in global perspective]</li>
<li id="cite_note-20"><b><a href="#cite_ref-20" title="">^</a></b> AJ Giannini. Alexythymia,affective disorders and substance abuse:possible cross relationships. Psychological Reports.78:1389-1391, 1996.</li>
<li id="cite_note-21"><b><a href="#cite_ref-21" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJohnson_RE.2C_Chutuape_MA.2C_Strain_EC.2C_Walsh_SL.2C_Stitzer_ML.2C_Bigelow_GE2000">Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE (2000). "A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence". <i>N. Engl. J. Med.</i> <b>343</b> (18): 1290–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJM200011023431802" class="external text" title="http://dx.doi.org/10.1056%2FNEJM200011023431802" rel="nofollow">10.1056/NEJM200011023431802</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11058673" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11058673">PMID 11058673</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+comparison+of+levomethadyl+acetate%2C+buprenorphine%2C+and+methadone+for+opioid+dependence&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Johnson+RE%2C+Chutuape+MA%2C+Strain+EC%2C+Walsh+SL%2C+Stitzer+ML%2C+Bigelow+GE&amp;rft.au=Johnson+RE%2C+Chutuape+MA%2C+Strain+EC%2C+Walsh+SL%2C+Stitzer+ML%2C+Bigelow+GE&amp;rft.date=2000&amp;rft.volume=343&amp;rft.issue=18&amp;rft.pages=1290%E2%80%937&amp;rft_id=info:doi/10.1056%2FNEJM200011023431802&amp;rft_id=info:pmid/11058673&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-22"><b><a href="#cite_ref-22" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFConnock_M.2C_Juarez-Garcia_A.2C_Jowett_S.2C_.27.27et_al.27.272007">Connock M, Juarez-Garcia A, Jowett S, <i>et al</i> (2007). "Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation". <i>Health Technol Assess</i> <b>11</b> (9): 1–171, iii–iv. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17313907" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17313907">PMID 17313907</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Methadone+and+buprenorphine+for+the+management+of+opioid+dependence%3A+a+systematic+review+and+economic+evaluation&amp;rft.jtitle=Health+Technol+Assess&amp;rft.aulast=Connock+M%2C+Juarez-Garcia+A%2C+Jowett+S%2C+%27%27et+al%27%27&amp;rft.au=Connock+M%2C+Juarez-Garcia+A%2C+Jowett+S%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=11&amp;rft.issue=9&amp;rft.pages=1%E2%80%93171%2C+iii%E2%80%93iv&amp;rft_id=info:pmid/17313907&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-23"><b><a href="#cite_ref-23" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMarsch_LA.2C_Stephens_MA.2C_Mudric_T.2C_Strain_EC.2C_Bigelow_GE.2C_Johnson_RE2005">Marsch LA, Stephens MA, Mudric T, Strain EC, Bigelow GE, Johnson RE (2005). "Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence". <i>Exp Clin Psychopharmacol</i> <b>13</b> (4): 293–302. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1037%2F1064-1297.13.4.293" class="external text" title="http://dx.doi.org/10.1037%2F1064-1297.13.4.293" rel="nofollow">10.1037/1064-1297.13.4.293</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16366759" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16366759">PMID 16366759</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Predictors+of+outcome+in+LAAM%2C+buprenorphine%2C+and+methadone+treatment+for+opioid+dependence&amp;rft.jtitle=Exp+Clin+Psychopharmacol&amp;rft.aulast=Marsch+LA%2C+Stephens+MA%2C+Mudric+T%2C+Strain+EC%2C+Bigelow+GE%2C+Johnson+RE&amp;rft.au=Marsch+LA%2C+Stephens+MA%2C+Mudric+T%2C+Strain+EC%2C+Bigelow+GE%2C+Johnson+RE&amp;rft.date=2005&amp;rft.volume=13&amp;rft.issue=4&amp;rft.pages=293%E2%80%93302&amp;rft_id=info:doi/10.1037%2F1064-1297.13.4.293&amp;rft_id=info:pmid/16366759&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-24"><b><a href="#cite_ref-24" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRobertson_JR.2C_Raab_GM.2C_Bruce_M.2C_McKenzie_JS.2C_Storkey_HR.2C_Salter_A2006">Robertson JR, Raab GM, Bruce M, McKenzie JS, Storkey HR, Salter A (2006). "Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial". <i><a href="/wiki/Addiction_(journal)" title="Addiction (journal)">Addiction</a></i> <b>101</b> (12): 1752–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1360-0443.2006.01603.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1360-0443.2006.01603.x" rel="nofollow">10.1111/j.1360-0443.2006.01603.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17156174" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17156174">PMID 17156174</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Addressing+the+efficacy+of+dihydrocodeine+versus+methadone+as+an+alternative+maintenance+treatment+for+opiate+dependence%3A+A+randomized+controlled+trial&amp;rft.jtitle=%5B%5BAddiction+%28journal%29%7CAddiction%5D%5D&amp;rft.aulast=Robertson+JR%2C+Raab+GM%2C+Bruce+M%2C+McKenzie+JS%2C+Storkey+HR%2C+Salter+A&amp;rft.au=Robertson+JR%2C+Raab+GM%2C+Bruce+M%2C+McKenzie+JS%2C+Storkey+HR%2C+Salter+A&amp;rft.date=2006&amp;rft.volume=101&amp;rft.issue=12&amp;rft.pages=1752%E2%80%939&amp;rft_id=info:doi/10.1111%2Fj.1360-0443.2006.01603.x&amp;rft_id=info:pmid/17156174&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-25"><b><a href="#cite_ref-25" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFQin_Bo-Yi1998">Qin Bo-Yi (1998). "Advances in dihydroetorphine: From analgesia to detoxification". <i>Drug Development Research</i> <b>39</b> (2): 131–134. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F%28SICI%291098-2299%28199610%2939%3A2%3C131%3A%3AAID-DDR3%3E3.0.CO%3B2-Q" class="external text" title="http://dx.doi.org/10.1002%2F%28SICI%291098-2299%28199610%2939%3A2%3C131%3A%3AAID-DDR3%3E3.0.CO%3B2-Q" rel="nofollow">10.1002/(SICI)1098-2299(199610)39:2&lt;131::AID-DDR3&gt;3.0.CO;2-Q</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Advances+in+dihydroetorphine%3A+From+analgesia+to+detoxification&amp;rft.jtitle=Drug+Development+Research&amp;rft.aulast=Qin+Bo-Yi&amp;rft.au=Qin+Bo-Yi&amp;rft.date=1998&amp;rft.volume=39&amp;rft.issue=2&amp;rft.pages=131%E2%80%93134&amp;rft_id=info:doi/10.1002%2F%28SICI%291098-2299%28199610%2939%3A2%3C131%3A%3AAID-DDR3%3E3.0.CO%3B2-Q&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span> <a href="http://www3.interscience.wiley.com/cgi-bin/abstract/67067/ABSTRACT?CRETRY=1&amp;SRETRY=0" class="external text" title="http://www3.interscience.wiley.com/cgi-bin/abstract/67067/ABSTRACT?CRETRY=1&amp;SRETRY=0" rel="nofollow">Link</a></li>
<li id="cite_note-Metrebian1-26"><b><a href="#cite_ref-Metrebian1_26-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMetrebian_N.2C_Shanahan_W.2C_Wells_B.2C_Stimson_GV1998">Metrebian N, Shanahan W, Wells B, Stimson GV (1998). "Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions". <i>Med. J. Aust.</i> <b>168</b> (12): 596–600. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9673620" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9673620">PMID 9673620</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Feasibility+of+prescribing+injectable+heroin+and+methadone+to+opiate-dependent+drug+users%3A+associated+health+gains+and+harm+reductions&amp;rft.jtitle=Med.+J.+Aust.&amp;rft.aulast=Metrebian+N%2C+Shanahan+W%2C+Wells+B%2C+Stimson+GV&amp;rft.au=Metrebian+N%2C+Shanahan+W%2C+Wells+B%2C+Stimson+GV&amp;rft.date=1998&amp;rft.volume=168&amp;rft.issue=12&amp;rft.pages=596%E2%80%93600&amp;rft_id=info:pmid/9673620&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Metrebian2-27"><b><a href="#cite_ref-Metrebian2_27-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMetrebian_N.2C_Mott_J.2C_Carnwath_Z.2C_Carnwath_T.2C_Stimson_GV.2C_Sell_L2007">Metrebian N, Mott J, Carnwath Z, Carnwath T, Stimson GV, Sell L (2007). "Pathways into receiving a prescription for diamorphine (heroin) for the treatment of opiate dependence in the United kingdom". <i>Eur Addict Res</i> <b>13</b> (3): 144–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1159%2F000101550" class="external text" title="http://dx.doi.org/10.1159%2F000101550" rel="nofollow">10.1159/000101550</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17570910" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17570910">PMID 17570910</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pathways+into+receiving+a+prescription+for+diamorphine+%28heroin%29+for+the+treatment+of+opiate+dependence+in+the+United+kingdom&amp;rft.jtitle=Eur+Addict+Res&amp;rft.aulast=Metrebian+N%2C+Mott+J%2C+Carnwath+Z%2C+Carnwath+T%2C+Stimson+GV%2C+Sell+L&amp;rft.au=Metrebian+N%2C+Mott+J%2C+Carnwath+Z%2C+Carnwath+T%2C+Stimson+GV%2C+Sell+L&amp;rft.date=2007&amp;rft.volume=13&amp;rft.issue=3&amp;rft.pages=144%E2%80%937&amp;rft_id=info:doi/10.1159%2F000101550&amp;rft_id=info:pmid/17570910&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-28"><b><a href="#cite_ref-28" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKenna_GA.2C_Nielsen_DM.2C_Mello_P.2C_Schiesl_A.2C_Swift_RM2007">Kenna GA, Nielsen DM, Mello P, Schiesl A, Swift RM (2007). "Pharmacotherapy of dual substance abuse and dependence". <i>CNS Drugs</i> <b>21</b> (3): 213–37. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2165%2F00023210-200721030-00003" class="external text" title="http://dx.doi.org/10.2165%2F00023210-200721030-00003" rel="nofollow">10.2165/00023210-200721030-00003</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17338593" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17338593">PMID 17338593</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pharmacotherapy+of+dual+substance+abuse+and+dependence&amp;rft.jtitle=CNS+Drugs&amp;rft.aulast=Kenna+GA%2C+Nielsen+DM%2C+Mello+P%2C+Schiesl+A%2C+Swift+RM&amp;rft.au=Kenna+GA%2C+Nielsen+DM%2C+Mello+P%2C+Schiesl+A%2C+Swift+RM&amp;rft.date=2007&amp;rft.volume=21&amp;rft.issue=3&amp;rft.pages=213%E2%80%9337&amp;rft_id=info:doi/10.2165%2F00023210-200721030-00003&amp;rft_id=info:pmid/17338593&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-29"><b><a href="#cite_ref-29" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMattick_RP.2C_Darke_S1995">Mattick RP, Darke S (1995). "Drug replacement treatments: is amphetamine substitution a horse of a different colour?". <i>Drug Alcohol Rev</i> <b>14</b> (4): 389–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1080%2F09595239500185531" class="external text" title="http://dx.doi.org/10.1080%2F09595239500185531" rel="nofollow">10.1080/09595239500185531</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16203339" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16203339">PMID 16203339</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Drug+replacement+treatments%3A+is+amphetamine+substitution+a+horse+of+a+different+colour%3F&amp;rft.jtitle=Drug+Alcohol+Rev&amp;rft.aulast=Mattick+RP%2C+Darke+S&amp;rft.au=Mattick+RP%2C+Darke+S&amp;rft.date=1995&amp;rft.volume=14&amp;rft.issue=4&amp;rft.pages=389%E2%80%9394&amp;rft_id=info:doi/10.1080%2F09595239500185531&amp;rft_id=info:pmid/16203339&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-30"><b><a href="#cite_ref-30" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWhite_R2000">White R (2000). "Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation". <i><a href="/wiki/Addiction_(journal)" title="Addiction (journal)">Addiction</a></i> <b>95</b> (2): 229–38. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1046%2Fj.1360-0443.2000.9522299.x" class="external text" title="http://dx.doi.org/10.1046%2Fj.1360-0443.2000.9522299.x" rel="nofollow">10.1046/j.1360-0443.2000.9522299.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10723851" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10723851">PMID 10723851</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Dexamphetamine+substitution+in+the+treatment+of+amphetamine+abuse%3A+an+initial+investigation&amp;rft.jtitle=%5B%5BAddiction+%28journal%29%7CAddiction%5D%5D&amp;rft.aulast=White+R&amp;rft.au=White+R&amp;rft.date=2000&amp;rft.volume=95&amp;rft.issue=2&amp;rft.pages=229%E2%80%9338&amp;rft_id=info:doi/10.1046%2Fj.1360-0443.2000.9522299.x&amp;rft_id=info:pmid/10723851&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-31"><b><a href="#cite_ref-31" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMajumdar_SK1991">Majumdar SK (1991). "Chlormethiazole: current status in the treatment of the acute ethanol withdrawal syndrome". <i>Drug Alcohol Depend</i> <b>27</b> (3): 201–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2F0376-8716%2891%2990001-F" class="external text" title="http://dx.doi.org/10.1016%2F0376-8716%2891%2990001-F" rel="nofollow">10.1016/0376-8716(91)90001-F</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1884662" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1884662">PMID 1884662</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Chlormethiazole%3A+current+status+in+the+treatment+of+the+acute+ethanol+withdrawal+syndrome&amp;rft.jtitle=Drug+Alcohol+Depend&amp;rft.aulast=Majumdar+SK&amp;rft.au=Majumdar+SK&amp;rft.date=1991&amp;rft.volume=27&amp;rft.issue=3&amp;rft.pages=201%E2%80%937&amp;rft_id=info:doi/10.1016%2F0376-8716%2891%2990001-F&amp;rft_id=info:pmid/1884662&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-32"><b><a href="#cite_ref-32" title="">^</a></b> AJ Giannini,TA Billet. Bromocriptine-desipramine protocol in cocaine detoxification. Journal of Clinical Pharmacology. 27:549-554,1987.</li>
<li id="cite_note-33"><b><a href="#cite_ref-33" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSoyka_M.2C_Roesner_S2006">Soyka M, Roesner S (2006). "New pharmacological approaches for the treatment of alcoholism". <i>Expert Opin Pharmacother</i> <b>7</b> (17): 2341–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1517%2F14656566.7.17.2341" class="external text" title="http://dx.doi.org/10.1517%2F14656566.7.17.2341" rel="nofollow">10.1517/14656566.7.17.2341</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17109610" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17109610">PMID 17109610</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=New+pharmacological+approaches+for+the+treatment+of+alcoholism&amp;rft.jtitle=Expert+Opin+Pharmacother&amp;rft.aulast=Soyka+M%2C+Roesner+S&amp;rft.au=Soyka+M%2C+Roesner+S&amp;rft.date=2006&amp;rft.volume=7&amp;rft.issue=17&amp;rft.pages=2341%E2%80%9353&amp;rft_id=info:doi/10.1517%2F14656566.7.17.2341&amp;rft_id=info:pmid/17109610&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-34"><b><a href="#cite_ref-34" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPettinati_HM.2C_Rabinowitz_AR2006">Pettinati HM, Rabinowitz AR (2006). "Choosing the right medication for the treatment of alcoholism". <i>Curr Psychiatry Rep</i> <b>8</b> (5): 383–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs11920-006-0040-0" class="external text" title="http://dx.doi.org/10.1007%2Fs11920-006-0040-0" rel="nofollow">10.1007/s11920-006-0040-0</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16968619" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16968619">PMID 16968619</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Choosing+the+right+medication+for+the+treatment+of+alcoholism&amp;rft.jtitle=Curr+Psychiatry+Rep&amp;rft.aulast=Pettinati+HM%2C+Rabinowitz+AR&amp;rft.au=Pettinati+HM%2C+Rabinowitz+AR&amp;rft.date=2006&amp;rft.volume=8&amp;rft.issue=5&amp;rft.pages=383%E2%80%938&amp;rft_id=info:doi/10.1007%2Fs11920-006-0040-0&amp;rft_id=info:pmid/16968619&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-35"><b><a href="#cite_ref-35" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBouza_C.2C_Angeles_M.2C_Magro_A.2C_Mu.C3.B1oz_A.2C_Amate_JM2004">Bouza C, Angeles M, Magro A, Muñoz A, Amate JM (2004). "Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review". <i><a href="/wiki/Addiction_(journal)" title="Addiction (journal)">Addiction</a></i> <b>99</b> (7): 811–28. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1360-0443.2004.00763.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1360-0443.2004.00763.x" rel="nofollow">10.1111/j.1360-0443.2004.00763.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15200577" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15200577">PMID 15200577</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+and+safety+of+naltrexone+and+acamprosate+in+the+treatment+of+alcohol+dependence%3A+a+systematic+review&amp;rft.jtitle=%5B%5BAddiction+%28journal%29%7CAddiction%5D%5D&amp;rft.aulast=Bouza+C%2C+Angeles+M%2C+Magro+A%2C+Mu%C3%B1oz+A%2C+Amate+JM&amp;rft.au=Bouza+C%2C+Angeles+M%2C+Magro+A%2C+Mu%C3%B1oz+A%2C+Amate+JM&amp;rft.date=2004&amp;rft.volume=99&amp;rft.issue=7&amp;rft.pages=811%E2%80%9328&amp;rft_id=info:doi/10.1111%2Fj.1360-0443.2004.00763.x&amp;rft_id=info:pmid/15200577&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-36"><b><a href="#cite_ref-36" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWilliams_SH2005">Williams SH (2005). "Medications for treating alcohol dependence". <i>Am Fam Physician</i> <b>72</b> (9): 1775–80. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16300039" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16300039">PMID 16300039</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Medications+for+treating+alcohol+dependence&amp;rft.jtitle=Am+Fam+Physician&amp;rft.aulast=Williams+SH&amp;rft.au=Williams+SH&amp;rft.date=2005&amp;rft.volume=72&amp;rft.issue=9&amp;rft.pages=1775%E2%80%9380&amp;rft_id=info:pmid/16300039&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-37"><b><a href="#cite_ref-37" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGass_JT.2C_Olive_MF2008">Gass JT, Olive MF (2008). "Glutamatergic substrates of drug addiction and alcoholism". <i>Biochem. Pharmacol.</i> <b>75</b> (1): 218–65. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.bcp.2007.06.039" class="external text" title="http://dx.doi.org/10.1016%2Fj.bcp.2007.06.039" rel="nofollow">10.1016/j.bcp.2007.06.039</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17706608" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17706608">PMID 17706608</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Glutamatergic+substrates+of+drug+addiction+and+alcoholism&amp;rft.jtitle=Biochem.+Pharmacol.&amp;rft.aulast=Gass+JT%2C+Olive+MF&amp;rft.au=Gass+JT%2C+Olive+MF&amp;rft.date=2008&amp;rft.volume=75&amp;rft.issue=1&amp;rft.pages=218%E2%80%9365&amp;rft_id=info:doi/10.1016%2Fj.bcp.2007.06.039&amp;rft_id=info:pmid/17706608&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-38"><b><a href="#cite_ref-38" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSrisurapanont_M.2C_Jarusuraisin_N2005">Srisurapanont M, Jarusuraisin N (2005). "Opioid antagonists for alcohol dependence". <i>Cochrane Database Syst Rev</i> (1): CD001867. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F14651858.CD001867.pub2" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD001867.pub2" rel="nofollow">10.1002/14651858.CD001867.pub2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15674887" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15674887">PMID 15674887</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Opioid+antagonists+for+alcohol+dependence&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.aulast=Srisurapanont+M%2C+Jarusuraisin+N&amp;rft.au=Srisurapanont+M%2C+Jarusuraisin+N&amp;rft.date=2005&amp;rft.issue=1&amp;rft.pages=CD001867&amp;rft_id=info:doi/10.1002%2F14651858.CD001867.pub2&amp;rft_id=info:pmid/15674887&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-39"><b><a href="#cite_ref-39" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKarhuvaara_S.2C_Simojoki_K.2C_Virta_A.2C_.27.27et_al.27.272007">Karhuvaara S, Simojoki K, Virta A, <i>et al</i> (2007). "Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study". <i>Alcohol. Clin. Exp. Res.</i> <b>31</b> (7): 1179–87. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1530-0277.2007.00401.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1530-0277.2007.00401.x" rel="nofollow">10.1111/j.1530-0277.2007.00401.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17451401" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17451401">PMID 17451401</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Targeted+nalmefene+with+simple+medical+management+in+the+treatment+of+heavy+drinkers%3A+a+randomized+double-blind+placebo-controlled+multicenter+study&amp;rft.jtitle=Alcohol.+Clin.+Exp.+Res.&amp;rft.aulast=Karhuvaara+S%2C+Simojoki+K%2C+Virta+A%2C+%27%27et+al%27%27&amp;rft.au=Karhuvaara+S%2C+Simojoki+K%2C+Virta+A%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=31&amp;rft.issue=7&amp;rft.pages=1179%E2%80%9387&amp;rft_id=info:doi/10.1111%2Fj.1530-0277.2007.00401.x&amp;rft_id=info:pmid/17451401&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-40"><b><a href="#cite_ref-40" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFComer_SD.2C_Sullivan_MA.2C_Hulse_GK2007">Comer SD, Sullivan MA, Hulse GK (2007). "Sustained-release naltrexone: novel treatment for opioid dependence". <i>Expert Opin Investig Drugs</i> <b>16</b> (8): 1285–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1517%2F13543784.16.8.1285" class="external text" title="http://dx.doi.org/10.1517%2F13543784.16.8.1285" rel="nofollow">10.1517/13543784.16.8.1285</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17685876" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17685876">PMID 17685876</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sustained-release+naltrexone%3A+novel+treatment+for+opioid+dependence&amp;rft.jtitle=Expert+Opin+Investig+Drugs&amp;rft.aulast=Comer+SD%2C+Sullivan+MA%2C+Hulse+GK&amp;rft.au=Comer+SD%2C+Sullivan+MA%2C+Hulse+GK&amp;rft.date=2007&amp;rft.volume=16&amp;rft.issue=8&amp;rft.pages=1285%E2%80%9394&amp;rft_id=info:doi/10.1517%2F13543784.16.8.1285&amp;rft_id=info:pmid/17685876&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-41"><b><a href="#cite_ref-41" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLing_W.2C_Rawson_R.2C_Shoptaw_S.2C_Ling_W2006">Ling W, Rawson R, Shoptaw S, Ling W (2006). "Management of methamphetamine abuse and dependence". <i>Curr Psychiatry Rep</i> <b>8</b> (5): 345–54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs11920-006-0035-x" class="external text" title="http://dx.doi.org/10.1007%2Fs11920-006-0035-x" rel="nofollow">10.1007/s11920-006-0035-x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16968614" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16968614">PMID 16968614</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Management+of+methamphetamine+abuse+and+dependence&amp;rft.jtitle=Curr+Psychiatry+Rep&amp;rft.aulast=Ling+W%2C+Rawson+R%2C+Shoptaw+S%2C+Ling+W&amp;rft.au=Ling+W%2C+Rawson+R%2C+Shoptaw+S%2C+Ling+W&amp;rft.date=2006&amp;rft.volume=8&amp;rft.issue=5&amp;rft.pages=345%E2%80%9354&amp;rft_id=info:doi/10.1007%2Fs11920-006-0035-x&amp;rft_id=info:pmid/16968614&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-42"><b><a href="#cite_ref-42" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPreti_A2007">Preti A (2007). "New developments in the pharmacotherapy of cocaine abuse". <i>Addict Biol</i> <b>12</b> (2): 133–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1369-1600.2007.00061.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1369-1600.2007.00061.x" rel="nofollow">10.1111/j.1369-1600.2007.00061.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17508985" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17508985">PMID 17508985</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=New+developments+in+the+pharmacotherapy+of+cocaine+abuse&amp;rft.jtitle=Addict+Biol&amp;rft.aulast=Preti+A&amp;rft.au=Preti+A&amp;rft.date=2007&amp;rft.volume=12&amp;rft.issue=2&amp;rft.pages=133%E2%80%9351&amp;rft_id=info:doi/10.1111%2Fj.1369-1600.2007.00061.x&amp;rft_id=info:pmid/17508985&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-43"><b><a href="#cite_ref-43" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFUrschel_HC.2C_Hanselka_LL.2C_Gromov_I.2C_White_L.2C_Baron_M2007">Urschel HC, Hanselka LL, Gromov I, White L, Baron M (2007). "Open-label study of a proprietary treatment program targeting type A gamma-aminobutyric acid receptor dysregulation in methamphetamine dependence". <i>Mayo Clin. Proc.</i> <b>82</b> (10): 1170–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.4065%2F82.10.1170" class="external text" title="http://dx.doi.org/10.4065%2F82.10.1170" rel="nofollow">10.4065/82.10.1170</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17908523" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17908523">PMID 17908523</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Open-label+study+of+a+proprietary+treatment+program+targeting+type+A+gamma-aminobutyric+acid+receptor+dysregulation+in+methamphetamine+dependence&amp;rft.jtitle=Mayo+Clin.+Proc.&amp;rft.aulast=Urschel+HC%2C+Hanselka+LL%2C+Gromov+I%2C+White+L%2C+Baron+M&amp;rft.au=Urschel+HC%2C+Hanselka+LL%2C+Gromov+I%2C+White+L%2C+Baron+M&amp;rft.date=2007&amp;rft.volume=82&amp;rft.issue=10&amp;rft.pages=1170%E2%80%938&amp;rft_id=info:doi/10.4065%2F82.10.1170&amp;rft_id=info:pmid/17908523&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-44"><b><a href="#cite_ref-44" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGarwood_CL.2C_Potts_LA2007">Garwood CL, Potts LA (2007). "Emerging pharmacotherapies for smoking cessation". <i>Am J Health Syst Pharm</i> <b>64</b> (16): 1693–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2146%2Fajhp060427" class="external text" title="http://dx.doi.org/10.2146%2Fajhp060427" rel="nofollow">10.2146/ajhp060427</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17687057" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17687057">PMID 17687057</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Emerging+pharmacotherapies+for+smoking+cessation&amp;rft.jtitle=Am+J+Health+Syst+Pharm&amp;rft.aulast=Garwood+CL%2C+Potts+LA&amp;rft.au=Garwood+CL%2C+Potts+LA&amp;rft.date=2007&amp;rft.volume=64&amp;rft.issue=16&amp;rft.pages=1693%E2%80%938&amp;rft_id=info:doi/10.2146%2Fajhp060427&amp;rft_id=info:pmid/17687057&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-45"><b><a href="#cite_ref-45" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFrishman_WH2007">Frishman WH (2007). "Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations". <i>Prev Cardiol</i> <b>10</b> (2 Suppl 1): 10–22. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1520-037X.2007.05963.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1520-037X.2007.05963.x" rel="nofollow">10.1111/j.1520-037X.2007.05963.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17396063" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17396063">PMID 17396063</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Smoking+cessation+pharmacotherapy--nicotine+and+non-nicotine+preparations&amp;rft.jtitle=Prev+Cardiol&amp;rft.aulast=Frishman+WH&amp;rft.au=Frishman+WH&amp;rft.date=2007&amp;rft.volume=10&amp;rft.issue=2+Suppl+1&amp;rft.pages=10%E2%80%9322&amp;rft_id=info:doi/10.1111%2Fj.1520-037X.2007.05963.x&amp;rft_id=info:pmid/17396063&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-46"><b><a href="#cite_ref-46" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSiu_EC.2C_Tyndale_RF2007">Siu EC, Tyndale RF (2007). "Non-nicotinic therapies for smoking cessation". <i>Annu. Rev. Pharmacol. Toxicol.</i> <b>47</b>: 541–64. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1146%2Fannurev.pharmtox.47.120505.105354" class="external text" title="http://dx.doi.org/10.1146%2Fannurev.pharmtox.47.120505.105354" rel="nofollow">10.1146/annurev.pharmtox.47.120505.105354</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17209799" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17209799">PMID 17209799</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Non-nicotinic+therapies+for+smoking+cessation&amp;rft.jtitle=Annu.+Rev.+Pharmacol.+Toxicol.&amp;rft.aulast=Siu+EC%2C+Tyndale+RF&amp;rft.au=Siu+EC%2C+Tyndale+RF&amp;rft.date=2007&amp;rft.volume=47&amp;rft.pages=541%E2%80%9364&amp;rft_id=info:doi/10.1146%2Fannurev.pharmtox.47.120505.105354&amp;rft_id=info:pmid/17209799&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-47"><b><a href="#cite_ref-47" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAlper_KR.2C_Lotsof_HS.2C_Kaplan_CD2008">Alper KR, Lotsof HS, Kaplan CD (2008). "The ibogaine medical subculture". <i>J Ethnopharmacol</i> <b>115</b> (1): 9–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jep.2007.08.034" class="external text" title="http://dx.doi.org/10.1016%2Fj.jep.2007.08.034" rel="nofollow">10.1016/j.jep.2007.08.034</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18029124" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18029124">PMID 18029124</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+ibogaine+medical+subculture&amp;rft.jtitle=J+Ethnopharmacol&amp;rft.aulast=Alper+KR%2C+Lotsof+HS%2C+Kaplan+CD&amp;rft.au=Alper+KR%2C+Lotsof+HS%2C+Kaplan+CD&amp;rft.date=2008&amp;rft.volume=115&amp;rft.issue=1&amp;rft.pages=9%E2%80%9324&amp;rft_id=info:doi/10.1016%2Fj.jep.2007.08.034&amp;rft_id=info:pmid/18029124&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-48"><b><a href="#cite_ref-48" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLevi_MS.2C_Borne_RF2002">Levi MS, Borne RF (2002). "A review of chemical agents in the pharmacotherapy of addiction". <i>Curr. Med. Chem.</i> <b>9</b> (20): 1807–18. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12369879" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12369879">PMID 12369879</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+review+of+chemical+agents+in+the+pharmacotherapy+of+addiction&amp;rft.jtitle=Curr.+Med.+Chem.&amp;rft.aulast=Levi+MS%2C+Borne+RF&amp;rft.au=Levi+MS%2C+Borne+RF&amp;rft.date=2002&amp;rft.volume=9&amp;rft.issue=20&amp;rft.pages=1807%E2%80%9318&amp;rft_id=info:pmid/12369879&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-49"><b><a href="#cite_ref-49" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWerneke_U.2C_Turner_T.2C_Priebe_S2006">Werneke U, Turner T, Priebe S (2006). "Complementary medicines in psychiatry: review of effectiveness and safety". <i>Br J Psychiatry</i> <b>188</b>: 109–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1192%2Fbjp.188.2.109" class="external text" title="http://dx.doi.org/10.1192%2Fbjp.188.2.109" rel="nofollow">10.1192/bjp.188.2.109</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16449696" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16449696">PMID 16449696</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Complementary+medicines+in+psychiatry%3A+review+of+effectiveness+and+safety&amp;rft.jtitle=Br+J+Psychiatry&amp;rft.aulast=Werneke+U%2C+Turner+T%2C+Priebe+S&amp;rft.au=Werneke+U%2C+Turner+T%2C+Priebe+S&amp;rft.date=2006&amp;rft.volume=188&amp;rft.pages=109%E2%80%9321&amp;rft_id=info:doi/10.1192%2Fbjp.188.2.109&amp;rft_id=info:pmid/16449696&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-50"><b><a href="#cite_ref-50" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJordan_JB2006">Jordan JB (2006). "Acupuncture treatment for opiate addiction: a systematic review". <i>J Subst Abuse Treat</i> <b>30</b> (4): 309–14. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jsat.2006.02.005" class="external text" title="http://dx.doi.org/10.1016%2Fj.jsat.2006.02.005" rel="nofollow">10.1016/j.jsat.2006.02.005</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16716845" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16716845">PMID 16716845</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Acupuncture+treatment+for+opiate+addiction%3A+a+systematic+review&amp;rft.jtitle=J+Subst+Abuse+Treat&amp;rft.aulast=Jordan+JB&amp;rft.au=Jordan+JB&amp;rft.date=2006&amp;rft.volume=30&amp;rft.issue=4&amp;rft.pages=309%E2%80%9314&amp;rft_id=info:doi/10.1016%2Fj.jsat.2006.02.005&amp;rft_id=info:pmid/16716845&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-51"><b><a href="#cite_ref-51" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWhite_AR.2C_Rampes_H.2C_Campbell_JL2006">White AR, Rampes H, Campbell JL (2006). "Acupuncture and related interventions for smoking cessation". <i>Cochrane Database Syst Rev</i> (1): CD000009. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F14651858.CD000009.pub2" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD000009.pub2" rel="nofollow">10.1002/14651858.CD000009.pub2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16437420" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16437420">PMID 16437420</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Acupuncture+and+related+interventions+for+smoking+cessation&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.aulast=White+AR%2C+Rampes+H%2C+Campbell+JL&amp;rft.au=White+AR%2C+Rampes+H%2C+Campbell+JL&amp;rft.date=2006&amp;rft.issue=1&amp;rft.pages=CD000009&amp;rft_id=info:doi/10.1002%2F14651858.CD000009.pub2&amp;rft_id=info:pmid/16437420&amp;rfr_id=info:sid/en.wikipedia.org:Drug_addiction"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-DSM4-52"><b><a href="#cite_ref-DSM4_52-0" title="">^</a></b> <a href="http://www.behavenet.com/capsules/disorders/subdep.htm" class="external text" title="http://www.behavenet.com/capsules/disorders/subdep.htm" rel="nofollow">DSM-IV &amp; DSM-IV-TR:Substance Dependence</a></li>
<li id="cite_note-NIDA-53"><b><a href="#cite_ref-NIDA_53-0" title="">^</a></b> <a href="http://www.nida.nih.gov/pdf/monographs/30.pdf" class="external text" title="http://www.nida.nih.gov/pdf/monographs/30.pdf" rel="nofollow">Nils Bejerot in Theories of Drug abuse, Selected contemporary perspectives, page 246-255,</a> <a href="/wiki/National_Institute_on_Drug_Abuse" title="National Institute on Drug Abuse">NIDA</a>, 1980</li>
<li id="cite_note-54"><b><a href="#cite_ref-54" title="">^</a></b> DCA Hillman. The Chemical Muse. New York City,St. Martin's Press,2008</li>
</ol>
</div>
<p><a name="Sources" id="Sources"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=30" title="Edit section: Sources">edit</a>]</span> <span class="mw-headline">Sources</span></h2>
<ul>
<li><i>Romancing Opiates: Pharmacological Lies and the Addiction Bureaucracy</i> / <a href="/wiki/Anthony_Daniels_(psychiatrist)" title="Anthony Daniels (psychiatrist)">Theodore Dalrymple</a> (2008) <a href="/wiki/Special:BookSources/1594032254" class="internal">ISBN 1594032254</a></li>
<li><a href="http://www.dukeupress.edu/books.php3?isbn=978-0-8223-3881-9" class="external text" title="http://www.dukeupress.edu/books.php3?isbn=978-0-8223-3881-9" rel="nofollow"><i>The Cult of Pharmacology: How America Became the Most Troubled Drug Culture</i></a> by Richard DeGrandpre, Duke University Press, 2006.</li>
<li>Nestler, Eric and Malenka, Robert (March 2004). "The Addicted Brain". <i>Scientific American</i>, pg. 78-83.</li>
<li>Leavitt, Fred. The REAL Drug Abusers. Rowman &amp; Littlefield, 2003.</li>
</ul>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Drug_addiction&amp;action=edit&amp;section=31" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.dmoz.org/Health/Addictions/Substance_Abuse//" class="external text" title="http://www.dmoz.org/Health/Addictions/Substance_Abuse//" rel="nofollow">Drug addiction</a> at the <a href="/wiki/Open_Directory_Project" title="Open Directory Project">Open Directory Project</a></li>
</ul>


<!-- 
NewPP limit report
Preprocessor node count: 21781/1000000
Post-expand include size: 169095/2048000 bytes
Template argument size: 55394/2048000 bytes
Expensive parser function count: 2/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:102961-0!1!0!default!!en!2 and timestamp 20090331074525 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Drug_addiction">http://en.wikipedia.org/wiki/Drug_addiction</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Drug_addiction" title="Category:Drug addiction">Drug addiction</a></span> | <span dir='ltr'><a href="/wiki/Category:Substance-related_disorders" title="Category:Substance-related disorders">Substance-related disorders</a></span> | <span dir='ltr'><a href="/wiki/Category:Mental_health" title="Category:Mental health">Mental health</a></span> | <span dir='ltr'><a href="/wiki/Category:Alcohol_abuse" title="Category:Alcohol abuse">Alcohol abuse</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_December_2008" title="Category:Articles with unsourced statements since December 2008">Articles with unsourced statements since December 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_needing_additional_references_from_September_2007" title="Category:Articles needing additional references from September 2007">Articles needing additional references from September 2007</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Drug_addiction" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Drug_addiction" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Drug_addiction&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Drug_addiction&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Drug_addiction" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Drug_addiction" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Drug_addiction" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Drug_addiction&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Drug_addiction&amp;oldid=280769419" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Drug_addiction&amp;id=280769419">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-ar"><a href="http://ar.wikipedia.org/wiki/%D8%A5%D8%AF%D9%85%D8%A7%D9%86_%D9%85%D8%AE%D8%AF%D8%B1%D8%A7%D8%AA">العربية</a></li>
				<li class="interwiki-bn"><a href="http://bn.wikipedia.org/wiki/%E0%A6%AE%E0%A6%BE%E0%A6%A6%E0%A6%95%E0%A6%BE%E0%A6%B8%E0%A6%95%E0%A7%8D%E0%A6%A4%E0%A6%BF">বাংলা</a></li>
				<li class="interwiki-bg"><a href="http://bg.wikipedia.org/wiki/%D0%9F%D1%80%D0%B8%D1%81%D1%82%D1%80%D0%B0%D1%81%D1%82%D1%8F%D0%B2%D0%B0%D0%BD%D0%B5">Български</a></li>
				<li class="interwiki-ca"><a href="http://ca.wikipedia.org/wiki/Addicci%C3%B3">Català</a></li>
				<li class="interwiki-cs"><a href="http://cs.wikipedia.org/wiki/Z%C3%A1vislost">Česky</a></li>
				<li class="interwiki-da"><a href="http://da.wikipedia.org/wiki/Narkoman">Dansk</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Missbrauch_und_Abh%C3%A4ngigkeit">Deutsch</a></li>
				<li class="interwiki-et"><a href="http://et.wikipedia.org/wiki/S%C3%B5ltuvus_(narkoloogia)">Eesti</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Drogodependencia">Español</a></li>
				<li class="interwiki-eo"><a href="http://eo.wikipedia.org/wiki/Droga_dependeco">Esperanto</a></li>
				<li class="interwiki-fa"><a href="http://fa.wikipedia.org/wiki/%D8%A7%D8%B9%D8%AA%DB%8C%D8%A7%D8%AF">فارسی</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Toxicomanie">Français</a></li>
				<li class="interwiki-gl"><a href="http://gl.wikipedia.org/wiki/Adicci%C3%B3n">Galego</a></li>
				<li class="interwiki-ka"><a href="http://ka.wikipedia.org/wiki/%E1%83%9C%E1%83%90%E1%83%A0%E1%83%99%E1%83%9D%E1%83%9B%E1%83%90%E1%83%9C%E1%83%98%E1%83%90">ქართული</a></li>
				<li class="interwiki-ko"><a href="http://ko.wikipedia.org/wiki/%EC%95%BD%EB%AC%BC_%EC%A4%91%EB%8F%85">한국어</a></li>
				<li class="interwiki-hy"><a href="http://hy.wikipedia.org/wiki/%D4%B9%D5%B4%D6%80%D5%A1%D5%B4%D5%B8%D5%AC%D5%B8%D6%82%D5%A9%D5%B5%D5%B8%D6%82%D5%B6">Հայերեն</a></li>
				<li class="interwiki-hr"><a href="http://hr.wikipedia.org/wiki/Ovisnost">Hrvatski</a></li>
				<li class="interwiki-id"><a href="http://id.wikipedia.org/wiki/Kecanduan">Bahasa Indonesia</a></li>
				<li class="interwiki-is"><a href="http://is.wikipedia.org/wiki/F%C3%ADkn">Íslenska</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Tossicodipendenza">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/%D7%94%D7%AA%D7%9E%D7%9B%D7%A8%D7%95%D7%AA">עברית</a></li>
				<li class="interwiki-lt"><a href="http://lt.wikipedia.org/wiki/Narkomanija">Lietuvių</a></li>
				<li class="interwiki-hu"><a href="http://hu.wikipedia.org/wiki/F%C3%BCgg%C5%91s%C3%A9g">Magyar</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Verslaving">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E8%96%AC%E7%89%A9%E4%BE%9D%E5%AD%98%E7%97%87">日本語</a></li>
				<li class="interwiki-no"><a href="http://no.wikipedia.org/wiki/Narkomani">‪Norsk (bokmål)‬</a></li>
				<li class="interwiki-oc"><a href="http://oc.wikipedia.org/wiki/Adiccion">Occitan</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Narkomania">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Toxicomania">Português</a></li>
				<li class="interwiki-ro"><a href="http://ro.wikipedia.org/wiki/Dependen%C5%A3%C4%83">Română</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%9D%D0%B0%D1%80%D0%BA%D0%BE%D0%BC%D0%B0%D0%BD%D0%B8%D1%8F">Русский</a></li>
				<li class="interwiki-scn"><a href="http://scn.wikipedia.org/wiki/Divotu_(idiali)">Sicilianu</a></li>
				<li class="interwiki-simple"><a href="http://simple.wikipedia.org/wiki/Drug_addiction">Simple English</a></li>
				<li class="interwiki-sr"><a href="http://sr.wikipedia.org/wiki/%D0%9D%D0%B0%D1%80%D0%BA%D0%BE%D0%BC%D0%B0%D0%BD%D0%B8%D1%98%D0%B0">Српски / Srpski</a></li>
				<li class="interwiki-sh"><a href="http://sh.wikipedia.org/wiki/Ovisnost">Srpskohrvatski / Српскохрватски</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/P%C3%A4ihderiippuvuus">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Narkomani">Svenska</a></li>
				<li class="interwiki-tr"><a href="http://tr.wikipedia.org/wiki/Ba%C4%9F%C4%B1ml%C4%B1l%C4%B1k">Türkçe</a></li>
				<li class="interwiki-uk"><a href="http://uk.wikipedia.org/wiki/%D0%9D%D0%B0%D1%80%D0%BA%D0%BE%D0%BC%D0%B0%D0%BD%D1%96%D1%8F">Українська</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E8%97%A5%E7%89%A9%E6%88%90%E7%99%AE">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 31 March 2009, at 01:18.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv181 in 0.061 secs. --></body></html>
